Visible node/edge number:
Node colors:
Node labels:

show label of nodes with degree >=

Node sizes:
Edge colors:
Edge widths factor:
Layout:

gravity >=

edgeLength =

GRN in network:

Notice: IE browser need to manually refresh (F5) this page after resetting the network.

This regulatory network was inferred from the input dataset. The miRNAs and mRNAs are presented as round and rectangle nodes respectively. The numerical value popped up upon mouse over the gene node is the log2 transformed fold-change of the gene expression between the two groups. All of the nodes are clickable, and the detailed information of the miRNAs/mRNAs and related cancer pathway will be displayed in another window. The edges between nodes are supported by both interactions (predicted or experimentally verified) and correlations learnt from cancer dataset. The numerical value popped up upon mouse over the edge is the correlation beat value (effect size) between the two nodes. The experimental evidences of the edges reported in previous cancer studies are highlighted by red/orange color. All of these information can be accessed by the "mouse-over" action. This network shows a full map of the miRNA-mRNA regulation of the input gene list(s), and the hub miRNAs (with the high network degree/betweenness centrality) would be the potential cancer drivers or tumor suppressors. The full result table can be accessed in the "Regulations" tab.

"miRNACancerMAP" is also a network visualization tool for users to draw their regulatory network by personal customization. Users can set the complexity of the network by limiting the number of nodes or edges. And the color of the nodes can be defined by different categories of the mRNAs and miRNAs, such as Gene-Ontology, pathway, and expression status. Users can also select to use network degree or network betweenness centrality to define the node size. And edges can be black or colored by the correlation. Purple edge means negative correlation (mostly found between miRNA and mRNA), and blue edge means positive correlation (found in PPI or miRNA-miRNA sponge effect). We can also add the protein-protein interactions (PPI) into the network. This result will show the cluster of genes regulated by some specific miRNAs. Additionally, miRNA-miRNA edges can be added by the "miRNA sponge" button, presenting some clusters of miRNAs that have the interactions via sponge effect.

miRNA-gene regulations

(Download full result)

Num microRNA           Gene miRNA log2FC miRNA pvalue Gene log2FC Gene pvalue Interaction Correlation beta Correlation P-value PMID Reported in cancer studies
1 hsa-miR-590-3p ABCA1 -0.55 0.01219 -0.05 0.91935 miRanda -0.11 0.01412 NA
2 hsa-miR-590-3p ABCA6 -0.55 0.01219 0.66 0.00093 MirTarget; miRanda -0.16 0.01422 NA
3 hsa-miR-590-3p ABCA8 -0.55 0.01219 0.24 0.56297 miRanda -0.31 0 NA
4 hsa-miR-590-3p ABCB1 -0.55 0.01219 0.23 0.58114 miRanda -0.19 0.00036 NA
5 hsa-miR-590-3p ABCB5 -0.55 0.01219 0.15 0.71953 miRanda; mirMAP -0.2 0.02429 NA
6 hsa-miR-590-3p ABCC3 -0.55 0.01219 1.22 0.00452 mirMAP -0.29 0.00017 NA
7 hsa-miR-590-3p ABCC9 -0.55 0.01219 1.29 0.00223 miRanda; mirMAP -0.44 0 NA
8 hsa-miR-590-3p ABCD2 -0.55 0.01219 1.39 0 MirTarget; miRanda; mirMAP -0.38 0 NA
9 hsa-miR-590-3p ABCD3 -0.55 0.01219 0.47 0.47915 miRanda; mirMAP -0.11 0 NA
10 hsa-miR-590-3p ABCG2 -0.55 0.01219 1.61 5.0E-5 miRanda; mirMAP -0.19 0.0016 NA
11 hsa-miR-590-3p ABHD13 -0.55 0.01219 0.26 0.6188 MirTarget; PITA; miRanda; mirMAP -0.11 0 NA
12 hsa-miR-590-3p ABI2 -0.55 0.01219 0.17 0.81806 miRanda; mirMAP -0.11 0 NA
13 hsa-miR-590-3p ABI3BP -0.55 0.01219 0.97 0.01918 miRanda -0.16 0.01223 NA
14 hsa-miR-590-3p ABLIM1 -0.55 0.01219 0.68 0.3271 miRanda; mirMAP -0.1 0.03325 NA
15 hsa-miR-590-3p ABRA -0.55 0.01219 0.88 0.08618 miRanda; mirMAP -0.36 0.0019 NA
16 hsa-miR-590-3p ACER3 -0.55 0.01219 -0.11 0.83861 MirTarget; miRanda; mirMAP; miRNATAP -0.13 0.00995 NA
17 hsa-miR-590-3p ACOT11 -0.55 0.01219 1.34 0 mirMAP -0.4 0 NA
18 hsa-miR-590-3p ACOX2 -0.55 0.01219 1.79 0 miRanda -0.51 0 NA
19 hsa-miR-590-3p ACPP -0.55 0.01219 -0.69 0.61736 miRanda; miRNATAP -0.34 0.00035 NA
20 hsa-miR-590-3p ACSL3 -0.55 0.01219 -0.55 0.57115 MirTarget; miRanda; mirMAP -0.11 0.00858 NA
21 hsa-miR-590-3p ACSL4 -0.55 0.01219 1.24 0.01784 MirTarget; PITA; miRanda; mirMAP -0.28 0 NA
22 hsa-miR-590-3p ACSS3 -0.55 0.01219 1.68 0 miRanda -0.47 0 NA
23 hsa-miR-590-3p ACTC1 -0.55 0.01219 2.79 0 miRanda -0.8 0 NA
24 hsa-miR-590-3p ACTG2 -0.55 0.01219 1.48 0.17764 miRanda -0.62 0 NA
25 hsa-miR-590-3p ACTN1 -0.55 0.01219 0.75 0.42477 miRanda; miRNATAP -0.29 0 NA
26 hsa-miR-590-3p ACVR1 -0.55 0.01219 0.24 0.68397 miRanda -0.16 0 NA
27 hsa-miR-590-3p ADAM10 -0.55 0.01219 0.31 0.68294 MirTarget; PITA; miRanda -0.3 0 NA
28 hsa-miR-590-3p ADAM17 -0.55 0.01219 0.44 0.33882 mirMAP -0.14 4.0E-5 NA
29 hsa-miR-590-3p ADAM19 -0.55 0.01219 0.95 0.00728 miRanda -0.27 0 NA
30 hsa-miR-590-3p ADAM22 -0.55 0.01219 1.1 0.00086 MirTarget; PITA; miRanda; mirMAP -0.48 0 NA
31 hsa-miR-590-3p ADAM23 -0.55 0.01219 1.24 0 miRanda -0.38 0 NA
32 hsa-miR-590-3p ADAM28 -0.55 0.01219 1.29 0 miRanda -0.16 0.01616 NA
33 hsa-miR-590-3p ADAM33 -0.55 0.01219 0.8 0.03697 miRanda -0.27 6.0E-5 NA
34 hsa-miR-590-3p ADAM9 -0.55 0.01219 -0.05 0.9538 miRanda; mirMAP -0.17 8.0E-5 NA
35 hsa-miR-590-3p ADAMTS1 -0.55 0.01219 0.55 0.46743 miRanda -0.24 0.00035 NA
36 hsa-miR-590-3p ADAMTS19 -0.55 0.01219 0.31 0.50691 PITA; miRanda; mirMAP; miRNATAP -0.25 0.00729 NA
37 hsa-miR-590-3p ADAMTS5 -0.55 0.01219 1.85 0 PITA; miRanda; miRNATAP -0.45 0 NA
38 hsa-miR-590-3p ADAMTS8 -0.55 0.01219 0.79 0.01199 miRanda -0.36 0 NA
39 hsa-miR-590-3p ADAMTS9 -0.55 0.01219 0.61 0.13853 miRanda -0.25 0 NA
40 hsa-miR-590-3p ADAMTSL3 -0.55 0.01219 1.37 0.00218 miRanda -0.5 0 NA
41 hsa-miR-590-3p ADCY2 -0.55 0.01219 0.66 0.16796 mirMAP -0.26 3.0E-5 NA
42 hsa-miR-590-3p ADCY9 -0.55 0.01219 0.86 0.08003 miRanda -0.12 0.00056 NA
43 hsa-miR-590-3p ADCYAP1 -0.55 0.01219 0.39 0.28508 MirTarget; PITA; miRanda; miRNATAP -0.26 0.00756 NA
44 hsa-miR-590-3p ADH1B -0.55 0.01219 1.73 0 miRanda; mirMAP -0.33 0.00011 NA
45 hsa-miR-590-3p AEBP2 -0.55 0.01219 0.35 0.55193 MirTarget; PITA; miRanda; miRNATAP -0.1 0 NA
46 hsa-miR-590-3p AFAP1 -0.55 0.01219 0.36 0.57197 PITA; miRanda; miRNATAP -0.2 0 NA
47 hsa-miR-590-3p AFAP1L2 -0.55 0.01219 1.6 0.00079 miRanda; mirMAP -0.34 0 NA
48 hsa-miR-590-3p AFF2 -0.55 0.01219 1.72 0 PITA; miRanda; mirMAP; miRNATAP -0.52 0 NA
49 hsa-miR-590-3p AFF4 -0.55 0.01219 0.21 0.80572 MirTarget; PITA; miRanda; mirMAP; miRNATAP -0.14 0 NA
50 hsa-miR-590-3p AGL -0.55 0.01219 0.41 0.52743 PITA; miRanda; mirMAP; miRNATAP -0.15 0 NA
51 hsa-miR-590-3p AGPS -0.55 0.01219 0.9 0.06385 miRanda; mirMAP; miRNATAP -0.2 0 NA
52 hsa-miR-590-3p AHNAK -0.55 0.01219 0.39 0.7417 miRanda -0.22 0 NA
53 hsa-miR-590-3p AHR -0.55 0.01219 1.15 0.05482 MirTarget; miRanda; mirMAP -0.2 4.0E-5 NA
54 hsa-miR-590-3p AK7 -0.55 0.01219 0.56 0.0013 miRanda; mirMAP -0.22 6.0E-5 NA
55 hsa-miR-590-3p AKAP10 -0.55 0.01219 0.47 0.33981 miRanda; mirMAP -0.15 3.0E-5 NA
56 hsa-miR-590-3p AKAP11 -0.55 0.01219 0.69 0.3018 MirTarget; miRanda; miRNATAP -0.22 0 NA
57 hsa-miR-590-3p AKAP12 -0.55 0.01219 1 0.14377 miRanda; mirMAP -0.12 0.04506 NA
58 hsa-miR-590-3p AKAP13 -0.55 0.01219 0.29 0.71988 PITA; miRanda; mirMAP -0.14 0 NA
59 hsa-miR-590-3p AKAP2 -0.55 0.01219 1.63 0.00507 mirMAP -0.55 0 NA
60 hsa-miR-590-3p AKAP6 -0.55 0.01219 0.91 0.00021 MirTarget; PITA; miRanda; mirMAP -0.26 0 NA
61 hsa-miR-590-3p AKIRIN1 -0.55 0.01219 0.33 0.63326 miRanda -0.16 0 NA
62 hsa-miR-590-3p AKR1C1 -0.55 0.01219 1.02 0.00138 mirMAP -0.24 0.00097 NA
63 hsa-miR-590-3p AKR1C2 -0.55 0.01219 1.48 0 mirMAP -0.25 0.0024 NA
64 hsa-miR-590-3p ALAD -0.55 0.01219 0.89 0.18684 miRanda -0.11 0.00044 NA
65 hsa-miR-590-3p ALDH1L1 -0.55 0.01219 0.49 0.35455 miRanda -0.38 1.0E-5 NA
66 hsa-miR-590-3p ALDH1L2 -0.55 0.01219 1.86 0 MirTarget; miRanda; mirMAP -0.44 0 NA
67 hsa-miR-590-3p ALDH9A1 -0.55 0.01219 0.1 0.90441 miRanda -0.13 0 NA
68 hsa-miR-590-3p ALMS1 -0.55 0.01219 0.31 0.5807 miRanda; mirMAP -0.14 0 NA
69 hsa-miR-590-3p ALPK3 -0.55 0.01219 -0.08 0.83904 miRanda; mirMAP -0.12 0.01533 NA
70 hsa-miR-590-3p AMD1 -0.55 0.01219 -0.37 0.7192 miRanda; mirMAP -0.2 0.00043 NA
71 hsa-miR-590-3p AMIGO1 -0.55 0.01219 0.16 0.67698 miRanda -0.16 0 NA
72 hsa-miR-590-3p AMOT -0.55 0.01219 1.15 0.04099 mirMAP -0.29 0 NA
73 hsa-miR-590-3p AMOTL1 -0.55 0.01219 0.44 0.60474 mirMAP -0.2 0 NA
74 hsa-miR-590-3p AMOTL2 -0.55 0.01219 0.75 0.26618 miRanda -0.21 0 NA
75 hsa-miR-590-3p ANAPC1 -0.55 0.01219 0.17 0.75896 MirTarget; miRanda; mirMAP; miRNATAP -0.16 0 NA
76 hsa-miR-590-3p ANGPT1 -0.55 0.01219 2.13 0 PITA; miRanda; mirMAP -0.6 0 NA
77 hsa-miR-590-3p ANGPTL1 -0.55 0.01219 1.58 0 PITA; miRanda; mirMAP -0.54 0 NA
78 hsa-miR-590-3p ANK2 -0.55 0.01219 1.54 5.0E-5 MirTarget; PITA; miRanda -0.41 0 NA
79 hsa-miR-590-3p ANK3 -0.55 0.01219 -0.19 0.799 MirTarget; PITA; miRanda; mirMAP -0.11 0.01855 NA
80 hsa-miR-590-3p ANKFY1 -0.55 0.01219 0.12 0.86615 PITA; miRanda; mirMAP; miRNATAP -0.1 0 NA
81 hsa-miR-590-3p ANKRA2 -0.55 0.01219 0.04 0.93647 MirTarget; PITA; miRanda; mirMAP; miRNATAP -0.11 5.0E-5 NA
82 hsa-miR-590-3p ANKRD17 -0.55 0.01219 0.07 0.92751 miRanda; mirMAP; miRNATAP -0.11 0.00081 NA
83 hsa-miR-590-3p ANKRD29 -0.55 0.01219 0.26 0.54384 mirMAP -0.16 0.02021 NA
84 hsa-miR-590-3p ANKRD44 -0.55 0.01219 1.03 0 miRanda -0.21 0.00078 NA
85 hsa-miR-590-3p ANKRD50 -0.55 0.01219 0.04 0.94971 PITA; miRanda; mirMAP -0.15 0.00014 NA
86 hsa-miR-590-3p ANKRD6 -0.55 0.01219 0.32 0.42877 miRanda; mirMAP -0.23 0 NA
87 hsa-miR-590-3p ANKS1B -0.55 0.01219 0.27 0.1199 MirTarget; PITA; miRanda; mirMAP; miRNATAP -0.12 0.00455 NA
88 hsa-miR-590-3p ANO1 -0.55 0.01219 1.82 0.00156 miRanda -0.35 0 NA
89 hsa-miR-590-3p ANO4 -0.55 0.01219 1.15 0.0001 miRanda -0.46 0 NA
90 hsa-miR-590-3p ANO5 -0.55 0.01219 1.72 0 miRanda; mirMAP -0.57 0 NA
91 hsa-miR-590-3p ANO6 -0.55 0.01219 1.38 0.03425 MirTarget; miRanda; mirMAP -0.34 0 NA
92 hsa-miR-590-3p ANP32E -0.55 0.01219 1.31 0.01205 MirTarget; PITA; miRanda; mirMAP; miRNATAP -0.19 0 NA
93 hsa-miR-590-3p ANTXR1 -0.55 0.01219 1.17 0.13834 miRanda; mirMAP -0.35 0 NA
94 hsa-miR-590-3p ANTXR2 -0.55 0.01219 0.53 0.54073 PITA; miRanda; mirMAP; miRNATAP -0.16 0.00023 NA
95 hsa-miR-590-3p ANXA2 -0.55 0.01219 1.12 0.21345 miRanda -0.16 0.00057 NA
96 hsa-miR-590-3p ANXA9 -0.55 0.01219 0.93 0 miRanda -0.12 0.02855 NA
97 hsa-miR-590-3p AOX1 -0.55 0.01219 2.43 0 miRanda -0.67 0 NA
98 hsa-miR-590-3p AP1S2 -0.55 0.01219 0.71 0.06921 miRanda; mirMAP -0.11 0.00141 NA
99 hsa-miR-590-3p AP3B1 -0.55 0.01219 0.14 0.82763 mirMAP -0.13 0 NA
100 hsa-miR-590-3p AP4E1 -0.55 0.01219 0.43 0.27016 PITA; miRanda -0.13 0 NA
101 hsa-miR-590-3p APC -0.55 0.01219 0.3 0.61191 PITA; miRanda; mirMAP; miRNATAP -0.17 0 NA
102 hsa-miR-590-3p APCDD1L -0.55 0.01219 1.55 7.0E-5 miRanda -0.53 0 NA
103 hsa-miR-590-3p APLF -0.55 0.01219 0.92 0 miRanda -0.23 0 NA
104 hsa-miR-590-3p APOBEC3F -0.55 0.01219 1.12 0.00255 miRanda -0.25 2.0E-5 NA
105 hsa-miR-590-3p APOBEC3G -0.55 0.01219 1.79 0 miRanda -0.21 0.00058 NA
106 hsa-miR-590-3p APOL4 -0.55 0.01219 0.23 0.68937 miRanda; mirMAP -0.31 0.00018 NA
107 hsa-miR-590-3p APP -0.55 0.01219 0.27 0.80727 miRanda -0.2 0 NA
108 hsa-miR-590-3p AQP2 -0.55 0.01219 4.49 0 mirMAP -0.33 0.02395 NA
109 hsa-miR-590-3p AQP3 -0.55 0.01219 0.51 0.5362 miRanda -0.11 0.04173 NA
110 hsa-miR-590-3p AQP4 -0.55 0.01219 1.08 1.0E-5 PITA; miRanda; mirMAP; miRNATAP -0.25 0.00024 NA
111 hsa-miR-590-3p AQP9 -0.55 0.01219 1.19 3.0E-5 miRanda; mirMAP; miRNATAP -0.2 0.01365 NA
112 hsa-miR-590-3p AQR -0.55 0.01219 0.18 0.77737 miRanda -0.12 2.0E-5 NA
113 hsa-miR-590-3p AR -0.55 0.01219 0.54 0.3489 mirMAP; miRNATAP -0.2 0.00719 NA
114 hsa-miR-590-3p ARAP3 -0.55 0.01219 0.71 0.08906 mirMAP -0.15 0.00043 NA
115 hsa-miR-590-3p AREG -0.55 0.01219 0.39 0.2247 miRanda -0.31 0.00276 NA
116 hsa-miR-590-3p ARFGEF2 -0.55 0.01219 0.31 0.67698 MirTarget; PITA; miRanda; mirMAP -0.16 0 NA
117 hsa-miR-590-3p ARHGAP10 -0.55 0.01219 0.74 0.16086 miRanda -0.17 1.0E-5 NA
118 hsa-miR-590-3p ARHGAP23 -0.55 0.01219 1.48 0.00496 miRanda -0.4 0 NA
119 hsa-miR-590-3p ARHGAP24 -0.55 0.01219 0.99 0.00079 miRanda; mirMAP -0.27 0 NA
120 hsa-miR-590-3p ARHGAP29 -0.55 0.01219 0.01 0.99278 miRanda; mirMAP -0.11 0.00296 NA
121 hsa-miR-590-3p ARHGAP31 -0.55 0.01219 0.63 0.15107 miRanda; mirMAP; miRNATAP -0.17 6.0E-5 NA
122 hsa-miR-590-3p ARHGAP42 -0.55 0.01219 0.35 0.17939 MirTarget; miRanda; mirMAP -0.19 4.0E-5 NA
123 hsa-miR-590-3p ARHGAP5 -0.55 0.01219 0.46 0.54675 MirTarget; PITA; miRanda; mirMAP; miRNATAP -0.16 0 NA
124 hsa-miR-590-3p ARHGEF11 -0.55 0.01219 0.26 0.6997 miRanda -0.11 1.0E-5 NA
125 hsa-miR-590-3p ARHGEF12 -0.55 0.01219 0.25 0.77866 PITA; miRanda; mirMAP; miRNATAP -0.13 1.0E-5 NA
126 hsa-miR-590-3p ARHGEF2 -0.55 0.01219 0.74 0.16972 miRanda; miRNATAP -0.12 0.00019 NA
127 hsa-miR-590-3p ARHGEF3 -0.55 0.01219 0.42 0.50649 mirMAP -0.12 0.00026 NA
128 hsa-miR-590-3p ARHGEF6 -0.55 0.01219 0.57 0.18792 miRanda; mirMAP -0.12 0.00172 NA
129 hsa-miR-590-3p ARHGEF9 -0.55 0.01219 0.54 0.33181 PITA; miRanda; mirMAP; miRNATAP -0.17 0 NA
130 hsa-miR-590-3p ARID1B -0.55 0.01219 0.26 0.72952 miRanda; mirMAP -0.11 0.00273 NA
131 hsa-miR-590-3p ARID4A -0.55 0.01219 0.42 0.42643 MirTarget; PITA; miRanda; mirMAP; miRNATAP -0.12 0 NA
132 hsa-miR-590-3p ARL10 -0.55 0.01219 1.24 0 mirMAP -0.31 0 NA
133 hsa-miR-590-3p ARL15 -0.55 0.01219 -0.02 0.95988 miRanda; mirMAP -0.17 0 NA
134 hsa-miR-590-3p ARL5B -0.55 0.01219 0.07 0.86764 MirTarget; miRanda; mirMAP -0.13 0.00335 NA
135 hsa-miR-590-3p ARMCX2 -0.55 0.01219 0.61 0.32669 miRanda -0.24 0 NA
136 hsa-miR-590-3p ARNT2 -0.55 0.01219 -0.09 0.87472 PITA; miRanda; miRNATAP -0.2 0 NA
137 hsa-miR-590-3p ARNTL -0.55 0.01219 0.61 0.04556 miRanda -0.1 0.00448 NA
138 hsa-miR-590-3p ARNTL2 -0.55 0.01219 0.92 0.00079 MirTarget -0.26 0.00086 NA
139 hsa-miR-590-3p ARPP19 -0.55 0.01219 0.39 0.6252 MirTarget; miRanda; mirMAP -0.1 0 NA
140 hsa-miR-590-3p ARRDC3 -0.55 0.01219 0.62 0.41308 mirMAP -0.17 1.0E-5 NA
141 hsa-miR-590-3p ARSB -0.55 0.01219 0.3 0.4943 PITA; miRanda; mirMAP; miRNATAP -0.22 0 NA
142 hsa-miR-590-3p ARSE -0.55 0.01219 0.6 0.03411 miRanda -0.32 0 NA
143 hsa-miR-590-3p ARSJ -0.55 0.01219 0.88 0.01189 miRanda; mirMAP -0.34 0 NA
144 hsa-miR-590-3p ARSK -0.55 0.01219 0.52 0.19282 miRanda -0.16 0 NA
145 hsa-miR-590-3p ART3 -0.55 0.01219 0.58 0.15673 miRanda -0.46 0 NA
146 hsa-miR-590-3p ASAH2B -0.55 0.01219 0.26 0.46133 mirMAP -0.32 0.00041 NA
147 hsa-miR-590-3p ASAP1 -0.55 0.01219 0.72 0.18256 MirTarget; miRanda; mirMAP -0.16 2.0E-5 NA
148 hsa-miR-590-3p ASB1 -0.55 0.01219 0.41 0.41312 mirMAP -0.12 0 NA
149 hsa-miR-590-3p ASB5 -0.55 0.01219 0.33 0.34548 miRanda; mirMAP -0.31 0.00039 NA
150 hsa-miR-590-3p ASCC3 -0.55 0.01219 0.34 0.59066 MirTarget; PITA; miRanda; mirMAP -0.19 1.0E-5 NA

Over-represented Gene Ontology Biological Process

NumGOOverlapSizeP ValueAdj. P Value
1 TISSUE DEVELOPMENT 334 1518 1.115e-37 5.187e-34
2 NEUROGENESIS 311 1402 1.105e-35 1.558e-32
3 CARDIOVASCULAR SYSTEM DEVELOPMENT 210 788 1.339e-35 1.558e-32
4 CIRCULATORY SYSTEM DEVELOPMENT 210 788 1.339e-35 1.558e-32
5 CELL DEVELOPMENT 308 1426 4.718e-33 4.391e-30
6 REGULATION OF CELL DIFFERENTIATION 317 1492 1.211e-32 9.39e-30
7 REGULATION OF MULTICELLULAR ORGANISMAL DEVELOPMENT 340 1672 3.391e-31 2.254e-28
8 REGULATION OF CELLULAR COMPONENT MOVEMENT 192 771 1.938e-28 1.127e-25
9 REGULATION OF NERVOUS SYSTEM DEVELOPMENT 185 750 7.021e-27 3.361e-24
10 POSITIVE REGULATION OF DEVELOPMENTAL PROCESS 248 1142 7.223e-27 3.361e-24
11 REGULATION OF CELL DEVELOPMENT 198 836 2.475e-26 1.047e-23
12 BIOLOGICAL ADHESION 228 1032 8.969e-26 3.478e-23
13 VASCULATURE DEVELOPMENT 132 469 5.482e-25 1.962e-22
14 HEART DEVELOPMENT 131 466 9.403e-25 3.125e-22
15 POSITIVE REGULATION OF MULTICELLULAR ORGANISMAL PROCESS 279 1395 2.739e-24 8.496e-22
16 CELL MORPHOGENESIS INVOLVED IN DIFFERENTIATION 138 513 5.202e-24 1.513e-21
17 RESPONSE TO ENDOGENOUS STIMULUS 285 1450 1.333e-23 3.649e-21
18 CELLULAR RESPONSE TO ENDOGENOUS STIMULUS 218 1008 2.16e-23 5.583e-21
19 LOCOMOTION 234 1114 2.761e-23 6.762e-21
20 NEURON DIFFERENTIATION 196 874 5.136e-23 1.195e-20
21 EPITHELIUM DEVELOPMENT 206 945 1.447e-22 3.207e-20
22 REGULATION OF NEURON DIFFERENTIATION 142 554 1.727e-22 3.653e-20
23 BLOOD VESSEL MORPHOGENESIS 107 364 4.681e-22 9.469e-20
24 TISSUE MORPHOGENESIS 137 533 7.497e-22 1.453e-19
25 REGULATION OF ANATOMICAL STRUCTURE MORPHOGENESIS 215 1021 1.464e-21 2.724e-19
26 POSITIVE REGULATION OF CELL DIFFERENTIATION 183 823 4.221e-21 7.554e-19
27 NEURON PROJECTION DEVELOPMENT 137 545 6.618e-21 1.141e-18
28 REGULATION OF PHOSPHORUS METABOLIC PROCESS 299 1618 1.797e-20 2.985e-18
29 CELLULAR COMPONENT MORPHOGENESIS 193 900 2.477e-20 3.974e-18
30 POSITIVE REGULATION OF CELL COMMUNICATION 286 1532 3.132e-20 4.858e-18
31 REGULATION OF INTRACELLULAR SIGNAL TRANSDUCTION 302 1656 8.556e-20 1.284e-17
32 CENTRAL NERVOUS SYSTEM DEVELOPMENT 187 872 1.008e-19 1.465e-17
33 ORGAN MORPHOGENESIS 182 841 1.179e-19 1.663e-17
34 POSITIVE REGULATION OF GENE EXPRESSION 312 1733 1.393e-19 1.907e-17
35 MOVEMENT OF CELL OR SUBCELLULAR COMPONENT 246 1275 2.731e-19 3.631e-17
36 POSITIVE REGULATION OF RESPONSE TO STIMULUS 336 1929 8.998e-19 1.163e-16
37 REGULATION OF TRANSCRIPTION FROM RNA POLYMERASE II PROMOTER 316 1784 9.66e-19 1.215e-16
38 NEURON DEVELOPMENT 155 687 1.265e-18 1.549e-16
39 REGULATION OF CELL PROLIFERATION 275 1496 1.662e-18 1.982e-16
40 HEAD DEVELOPMENT 158 709 1.987e-18 2.311e-16
41 NEGATIVE REGULATION OF RESPONSE TO STIMULUS 255 1360 2.644e-18 3e-16
42 POSITIVE REGULATION OF MOLECULAR FUNCTION 315 1791 3.247e-18 3.597e-16
43 TUBE DEVELOPMENT 132 552 3.332e-18 3.606e-16
44 ENZYME LINKED RECEPTOR PROTEIN SIGNALING PATHWAY 154 689 4.119e-18 4.356e-16
45 UROGENITAL SYSTEM DEVELOPMENT 87 299 7.334e-18 7.583e-16
46 CELL PROJECTION ORGANIZATION 186 902 9.696e-18 9.807e-16
47 ANATOMICAL STRUCTURE FORMATION INVOLVED IN MORPHOGENESIS 194 957 1.215e-17 1.203e-15
48 POSITIVE REGULATION OF NERVOUS SYSTEM DEVELOPMENT 111 437 1.653e-17 1.602e-15
49 CELL MOTILITY 175 835 1.836e-17 1.675e-15
50 EMBRYO DEVELOPMENT 184 894 1.806e-17 1.675e-15
51 LOCALIZATION OF CELL 175 835 1.836e-17 1.675e-15
52 MUSCLE STRUCTURE DEVELOPMENT 110 432 1.911e-17 1.71e-15
53 REGULATION OF CELL PROJECTION ORGANIZATION 131 558 2.252e-17 1.977e-15
54 POSITIVE REGULATION OF BIOSYNTHETIC PROCESS 313 1805 3.447e-17 2.97e-15
55 NEURON PROJECTION MORPHOGENESIS 104 402 4.473e-17 3.784e-15
56 REGULATION OF NEURON PROJECTION DEVELOPMENT 105 408 4.686e-17 3.894e-15
57 POSITIVE REGULATION OF LOCOMOTION 107 420 5.085e-17 4.151e-15
58 CELLULAR RESPONSE TO ORGANIC SUBSTANCE 318 1848 5.696e-17 4.57e-15
59 REGULATION OF CELL DEATH 266 1472 6.421e-17 5.064e-15
60 NEGATIVE REGULATION OF CELL COMMUNICATION 226 1192 7.61e-17 5.902e-15
61 MORPHOGENESIS OF AN EPITHELIUM 103 400 8.982e-17 6.851e-15
62 INTRACELLULAR SIGNAL TRANSDUCTION 279 1572 1.144e-16 8.54e-15
63 POSITIVE REGULATION OF TRANSCRIPTION FROM RNA POLYMERASE II PROMOTER 198 1004 1.156e-16 8.54e-15
64 MUSCLE TISSUE DEVELOPMENT 80 275 1.587e-16 1.154e-14
65 REGULATION OF TRANSPORT 310 1804 1.854e-16 1.327e-14
66 REGULATION OF PROTEIN MODIFICATION PROCESS 296 1710 3.745e-16 2.64e-14
67 NEGATIVE REGULATION OF DEVELOPMENTAL PROCESS 166 801 3.885e-16 2.698e-14
68 RESPONSE TO ORGANIC CYCLIC COMPOUND 183 917 5.507e-16 3.768e-14
69 REGULATION OF HYDROLASE ACTIVITY 242 1327 6.59e-16 4.444e-14
70 CELLULAR RESPONSE TO OXYGEN CONTAINING COMPOUND 165 799 6.732e-16 4.475e-14
71 RESPONSE TO HORMONE 179 893 7.565e-16 4.957e-14
72 RESPONSE TO WOUNDING 128 563 7.71e-16 4.983e-14
73 POSITIVE REGULATION OF CELL DEVELOPMENT 113 472 8.631e-16 5.501e-14
74 STEM CELL DIFFERENTIATION 62 190 1.117e-15 7.025e-14
75 CELL MORPHOGENESIS INVOLVED IN NEURON DIFFERENTIATION 95 368 1.205e-15 7.479e-14
76 POSITIVE REGULATION OF PHOSPHATE METABOLIC PROCESS 199 1036 1.639e-15 9.906e-14
77 POSITIVE REGULATION OF PHOSPHORUS METABOLIC PROCESS 199 1036 1.639e-15 9.906e-14
78 NEGATIVE REGULATION OF CELL DIFFERENTIATION 134 609 2.511e-15 1.498e-13
79 MESENCHYME DEVELOPMENT 61 190 4.441e-15 2.616e-13
80 POSITIVE REGULATION OF CELLULAR COMPONENT ORGANIZATION 214 1152 5.266e-15 3.063e-13
81 POSITIVE REGULATION OF CATALYTIC ACTIVITY 265 1518 6.002e-15 3.448e-13
82 MESENCHYMAL CELL DIFFERENTIATION 49 134 7.324e-15 4.156e-13
83 RESPONSE TO GROWTH FACTOR 111 475 9.33e-15 5.23e-13
84 RESPONSE TO OXYGEN CONTAINING COMPOUND 245 1381 1.143e-14 6.333e-13
85 REGULATION OF CELL MORPHOGENESIS 123 552 1.384e-14 7.574e-13
86 NEGATIVE REGULATION OF MULTICELLULAR ORGANISMAL PROCESS 188 983 1.632e-14 8.831e-13
87 CELL JUNCTION ORGANIZATION 59 185 1.741e-14 9.311e-13
88 RESPONSE TO LIPID 173 888 3.585e-14 1.896e-12
89 SINGLE ORGANISM BEHAVIOR 94 384 5.725e-14 2.993e-12
90 REGULATION OF MAPK CASCADE 138 660 6.603e-14 3.414e-12
91 TAXIS 107 464 7.225e-14 3.694e-12
92 ANGIOGENESIS 78 293 7.598e-14 3.843e-12
93 TUBE MORPHOGENESIS 83 323 1.018e-13 5.039e-12
94 BEHAVIOR 115 516 1.009e-13 5.039e-12
95 GLAND DEVELOPMENT 95 395 1.316e-13 6.447e-12
96 REGULATION OF EPITHELIAL CELL PROLIFERATION 76 285 1.441e-13 6.985e-12
97 REGULATION OF CELL MORPHOGENESIS INVOLVED IN DIFFERENTIATION 85 337 1.579e-13 7.574e-12
98 POSITIVE REGULATION OF CELL PROLIFERATION 160 814 1.611e-13 7.65e-12
99 REGULATION OF CELL ADHESION 132 629 1.78e-13 8.366e-12
100 AMEBOIDAL TYPE CELL MIGRATION 51 154 1.97e-13 9.168e-12
101 CELLULAR RESPONSE TO ORGANIC CYCLIC COMPOUND 106 465 2.085e-13 9.607e-12
102 REGULATION OF GTPASE ACTIVITY 138 673 3.137e-13 1.431e-11
103 MORPHOGENESIS OF A BRANCHING STRUCTURE 53 167 4.617e-13 2.086e-11
104 POSITIVE REGULATION OF CELL PROJECTION ORGANIZATION 78 303 5.106e-13 2.285e-11
105 GROWTH 96 410 5.432e-13 2.407e-11
106 RESPONSE TO STEROID HORMONE 110 497 5.652e-13 2.481e-11
107 POSITIVE REGULATION OF INTRACELLULAR SIGNAL TRANSDUCTION 167 876 7.014e-13 3.05e-11
108 POSITIVE REGULATION OF NEURON PROJECTION DEVELOPMENT 65 232 7.383e-13 3.181e-11
109 POSITIVE REGULATION OF NEURON DIFFERENTIATION 78 306 8.84e-13 3.774e-11
110 CELLULAR RESPONSE TO HORMONE STIMULUS 118 552 9.734e-13 4.117e-11
111 DEVELOPMENTAL GROWTH 82 333 1.673e-12 7.011e-11
112 SKELETAL SYSTEM DEVELOPMENT 102 455 1.766e-12 7.335e-11
113 POSITIVE REGULATION OF PROTEIN METABOLIC PROCESS 251 1492 2.273e-12 9.361e-11
114 DIGESTIVE SYSTEM DEVELOPMENT 48 148 2.381e-12 9.719e-11
115 POSITIVE REGULATION OF HYDROLASE ACTIVITY 169 905 3.063e-12 1.239e-10
116 CELL CELL ADHESION 125 608 3.528e-12 1.415e-10
117 SENSORY ORGAN DEVELOPMENT 107 493 4.27e-12 1.698e-10
118 PROTEIN PHOSPHORYLATION 174 944 4.478e-12 1.766e-10
119 EMBRYONIC MORPHOGENESIS 114 539 4.912e-12 1.904e-10
120 EXTRACELLULAR STRUCTURE ORGANIZATION 76 304 4.904e-12 1.904e-10
121 REGULATION OF SYSTEM PROCESS 109 507 5.017e-12 1.929e-10
122 POSITIVE REGULATION OF MAPK CASCADE 103 470 5.873e-12 2.24e-10
123 MUSCLE CELL DIFFERENTIATION 64 237 6.608e-12 2.5e-10
124 REGULATION OF KINASE ACTIVITY 149 776 7.437e-12 2.791e-10
125 REGULATION OF OSSIFICATION 53 178 7.521e-12 2.8e-10
126 DEVELOPMENTAL GROWTH INVOLVED IN MORPHOGENESIS 38 104 7.81e-12 2.884e-10
127 RESPONSE TO EXTERNAL STIMULUS 292 1821 9.524e-12 3.489e-10
128 NEGATIVE REGULATION OF NERVOUS SYSTEM DEVELOPMENT 68 262 1.057e-11 3.844e-10
129 HEART MORPHOGENESIS 59 212 1.138e-11 4.103e-10
130 FOREBRAIN DEVELOPMENT 84 357 1.181e-11 4.196e-10
131 CELL JUNCTION ASSEMBLY 43 129 1.177e-11 4.196e-10
132 NEGATIVE REGULATION OF CELL DEATH 162 872 1.353e-11 4.771e-10
133 WOUND HEALING 102 470 1.369e-11 4.791e-10
134 NEURAL CREST CELL DIFFERENTIATION 31 75 1.591e-11 5.526e-10
135 REGULATION OF EPITHELIAL CELL MIGRATION 50 166 1.834e-11 6.322e-10
136 CELLULAR RESPONSE TO NITROGEN COMPOUND 107 505 2.003e-11 6.852e-10
137 POSITIVE REGULATION OF PROTEIN MODIFICATION PROCESS 198 1135 2.471e-11 8.393e-10
138 POSITIVE REGULATION OF EPITHELIAL CELL MIGRATION 37 103 2.627e-11 8.858e-10
139 NEGATIVE REGULATION OF CELL DEVELOPMENT 74 303 3.091e-11 1.035e-09
140 RESPONSE TO NITROGEN COMPOUND 158 859 5.395e-11 1.793e-09
141 CARDIAC MUSCLE TISSUE DEVELOPMENT 44 140 6.256e-11 2.065e-09
142 RESPONSE TO ABIOTIC STIMULUS 181 1024 6.301e-11 2.065e-09
143 NEGATIVE REGULATION OF PHOSPHORUS METABOLIC PROCESS 111 541 6.682e-11 2.159e-09
144 NEGATIVE REGULATION OF PHOSPHATE METABOLIC PROCESS 111 541 6.682e-11 2.159e-09
145 REGULATION OF ANATOMICAL STRUCTURE SIZE 100 472 9.217e-11 2.958e-09
146 NEGATIVE REGULATION OF TRANSCRIPTION FROM RNA POLYMERASE II PROMOTER 140 740 9.65e-11 3.075e-09
147 REGULATION OF DEVELOPMENTAL GROWTH 70 289 1.559e-10 4.935e-09
148 CELLULAR RESPONSE TO LIPID 97 457 1.59e-10 4.966e-09
149 POSITIVE REGULATION OF EPITHELIAL CELL PROLIFERATION 46 154 1.589e-10 4.966e-09
150 DIGESTIVE TRACT MORPHOGENESIS 23 48 1.798e-10 5.578e-09
151 REGULATION OF HOMEOSTATIC PROCESS 95 447 2.286e-10 7.044e-09
152 CELL PART MORPHOGENESIS 123 633 2.453e-10 7.508e-09
153 CONNECTIVE TISSUE DEVELOPMENT 53 194 2.64e-10 8.027e-09
154 POSITIVE REGULATION OF CELL MORPHOGENESIS INVOLVED IN DIFFERENTIATION 47 162 3.012e-10 9.1e-09
155 BRANCHING MORPHOGENESIS OF AN EPITHELIAL TUBE 41 131 3.208e-10 9.631e-09
156 REGULATION OF CELLULAR RESPONSE TO GROWTH FACTOR STIMULUS 59 229 3.321e-10 9.905e-09
157 REGULATION OF CELLULAR COMPONENT BIOGENESIS 142 767 3.355e-10 9.943e-09
158 REGULATION OF ACTIN FILAMENT BASED PROCESS 73 312 3.422e-10 1.008e-08
159 GLAND MORPHOGENESIS 34 97 3.562e-10 1.042e-08
160 MUSCLE ORGAN DEVELOPMENT 67 277 4.088e-10 1.189e-08
161 TRANSMEMBRANE RECEPTOR PROTEIN TYROSINE KINASE SIGNALING PATHWAY 102 498 4.424e-10 1.278e-08
162 POSITIVE REGULATION OF OSSIFICATION 31 84 4.851e-10 1.393e-08
163 NEGATIVE REGULATION OF PHOSPHORYLATION 90 422 5.652e-10 1.613e-08
164 EMBRYO DEVELOPMENT ENDING IN BIRTH OR EGG HATCHING 110 554 6.131e-10 1.74e-08
165 CIRCULATORY SYSTEM PROCESS 81 366 6.608e-10 1.863e-08
166 NEGATIVE REGULATION OF CELL PROLIFERATION 123 643 6.782e-10 1.901e-08
167 NEURON PROJECTION GUIDANCE 54 205 7.744e-10 2.158e-08
168 NEURAL CREST CELL MIGRATION 23 51 8.207e-10 2.273e-08
169 RESPONSE TO ALCOHOL 80 362 9.04e-10 2.489e-08
170 MUSCLE SYSTEM PROCESS 67 282 9.15e-10 2.504e-08
171 POSITIVE REGULATION OF TRANSPORT 164 936 1.025e-09 2.789e-08
172 STRIATED MUSCLE CELL DIFFERENTIATION 48 173 1.033e-09 2.795e-08
173 REGULATION OF BLOOD CIRCULATION 69 295 1.053e-09 2.831e-08
174 EYE DEVELOPMENT 74 326 1.106e-09 2.956e-08
175 REGULATION OF AXONOGENESIS 47 168 1.141e-09 3.035e-08
176 NEGATIVE REGULATION OF NEURON DIFFERENTIATION 51 191 1.365e-09 3.608e-08
177 POSITIVE REGULATION OF KINASE ACTIVITY 98 482 1.464e-09 3.85e-08
178 COGNITION 61 251 2.019e-09 5.279e-08
179 REGULATION OF CELLULAR LOCALIZATION 209 1277 2.156e-09 5.604e-08
180 CARDIAC CHAMBER DEVELOPMENT 42 144 2.189e-09 5.66e-08
181 REGULATION OF TRANSFERASE ACTIVITY 164 946 2.266e-09 5.826e-08
182 REGULATION OF MAP KINASE ACTIVITY 72 319 2.402e-09 6.14e-08
183 SYNAPSE ORGANIZATION 42 145 2.756e-09 7.008e-08
184 KIDNEY EPITHELIUM DEVELOPMENT 38 125 3.526e-09 8.917e-08
185 CARTILAGE DEVELOPMENT 42 147 4.331e-09 1.089e-07
186 RESPONSE TO INORGANIC SUBSTANCE 96 479 4.657e-09 1.165e-07
187 REGULATION OF BODY FLUID LEVELS 100 506 4.798e-09 1.194e-07
188 NEGATIVE CHEMOTAXIS 19 39 4.888e-09 1.21e-07
189 REGULATION OF MEMBRANE POTENTIAL 75 343 4.932e-09 1.214e-07
190 REGULATION OF HEART CONTRACTION 55 221 5.03e-09 1.225e-07
191 ORGAN GROWTH 26 68 5.017e-09 1.225e-07
192 NEGATIVE REGULATION OF LOCOMOTION 62 263 5.3e-09 1.284e-07
193 PHOSPHATE CONTAINING COMPOUND METABOLIC PROCESS 298 1977 5.516e-09 1.33e-07
194 POSITIVE REGULATION OF AXONOGENESIS 26 69 7.207e-09 1.729e-07
195 NEGATIVE REGULATION OF INTRACELLULAR SIGNAL TRANSDUCTION 89 437 7.624e-09 1.819e-07
196 REGULATION OF SMALL GTPASE MEDIATED SIGNAL TRANSDUCTION 64 278 8.14e-09 1.932e-07
197 REGULATION OF SYNAPSE ORGANIZATION 35 113 8.424e-09 1.99e-07
198 BONE DEVELOPMENT 43 156 9.346e-09 2.185e-07
199 REGULATION OF TRANSMEMBRANE RECEPTOR PROTEIN SERINE THREONINE KINASE SIGNALING PATHWAY 52 207 9.302e-09 2.185e-07
200 REGULATION OF SYNAPSE ASSEMBLY 28 79 9.461e-09 2.19e-07
201 EMBRYONIC ORGAN DEVELOPMENT 84 406 9.419e-09 2.19e-07
202 SINGLE ORGANISM CELL ADHESION 92 459 9.703e-09 2.235e-07
203 REGULATION OF CELL SUBSTRATE ADHESION 46 173 9.943e-09 2.279e-07
204 POSITIVE REGULATION OF SYNAPSE ASSEMBLY 24 61 9.998e-09 2.28e-07
205 REGULATION OF SYNAPSE STRUCTURE OR ACTIVITY 56 232 1.185e-08 2.689e-07
206 REGULATION OF MUSCLE CELL DIFFERENTIATION 42 152 1.28e-08 2.877e-07
207 EPITHELIAL CELL DIFFERENTIATION 97 495 1.274e-08 2.877e-07
208 SPROUTING ANGIOGENESIS 20 45 1.418e-08 3.172e-07
209 MESONEPHROS DEVELOPMENT 30 90 1.464e-08 3.258e-07
210 LEARNING 38 131 1.48e-08 3.278e-07
211 ODONTOGENESIS 33 105 1.489e-08 3.285e-07
212 REGULATION OF PROTEIN SERINE THREONINE KINASE ACTIVITY 93 470 1.557e-08 3.417e-07
213 POSITIVE REGULATION OF ENDOTHELIAL CELL MIGRATION 25 67 1.763e-08 3.852e-07
214 SECOND MESSENGER MEDIATED SIGNALING 43 160 2.119e-08 4.608e-07
215 REGULATION OF ORGAN MORPHOGENESIS 57 242 2.24e-08 4.847e-07
216 REGULATION OF OSTEOBLAST DIFFERENTIATION 34 112 2.406e-08 5.182e-07
217 REGULATION OF CELL SIZE 45 172 2.444e-08 5.234e-07
218 REGULATION OF CYTOPLASMIC TRANSPORT 94 481 2.452e-08 5.234e-07
219 REGULATION OF CELLULAR COMPONENT SIZE 72 337 2.734e-08 5.808e-07
220 PHOSPHORYLATION 197 1228 3.138e-08 6.637e-07
221 SMOOTH MUSCLE TISSUE DEVELOPMENT 12 18 3.204e-08 6.746e-07
222 CARDIAC MUSCLE CELL DIFFERENTIATION 26 74 3.899e-08 8.173e-07
223 TELENCEPHALON DEVELOPMENT 54 228 4.271e-08 8.911e-07
224 POSITIVE REGULATION OF RESPONSE TO EXTERNAL STIMULUS 65 296 4.329e-08 8.992e-07
225 TRANSCRIPTION FROM RNA POLYMERASE II PROMOTER 128 724 4.384e-08 9.044e-07
226 TISSUE MIGRATION 28 84 4.393e-08 9.044e-07
227 POSITIVE REGULATION OF CELL DEATH 111 605 4.88e-08 1e-06
228 NEPHRON DEVELOPMENT 34 115 4.985e-08 1.017e-06
229 RESPONSE TO OXYGEN LEVELS 67 311 5.886e-08 1.196e-06
230 CELL PROLIFERATION 120 672 6.643e-08 1.344e-06
231 REGULATION OF RAS PROTEIN SIGNAL TRANSDUCTION 46 184 7.63e-08 1.537e-06
232 CARDIOCYTE DIFFERENTIATION 30 96 7.671e-08 1.539e-06
233 EXOCRINE SYSTEM DEVELOPMENT 19 45 8.969e-08 1.791e-06
234 MULTICELLULAR ORGANISMAL SIGNALING 35 123 9.191e-08 1.828e-06
235 MUSCLE CONTRACTION 54 233 9.232e-08 1.828e-06
236 CELLULAR RESPONSE TO EXTERNAL STIMULUS 59 264 9.403e-08 1.854e-06
237 CELL SUBSTRATE JUNCTION ASSEMBLY 18 41 9.465e-08 1.858e-06
238 REGULATION OF INTRACELLULAR TRANSPORT 112 621 1.076e-07 2.104e-06
239 REGULATION OF RESPONSE TO EXTERNAL STIMULUS 154 926 1.15e-07 2.24e-06
240 CELL GROWTH 37 135 1.158e-07 2.245e-06
241 REGULATION OF CELL JUNCTION ASSEMBLY 24 68 1.168e-07 2.256e-06
242 POSITIVE REGULATION OF TRANSFERASE ACTIVITY 111 616 1.286e-07 2.462e-06
243 NEGATIVE REGULATION OF PROTEIN MODIFICATION PROCESS 111 616 1.286e-07 2.462e-06
244 CELL SUBSTRATE ADHESION 42 164 1.35e-07 2.575e-06
245 RESPONSE TO CORTICOSTEROID 44 176 1.452e-07 2.75e-06
246 PALLIUM DEVELOPMENT 40 153 1.466e-07 2.75e-06
247 HOMOPHILIC CELL ADHESION VIA PLASMA MEMBRANE ADHESION MOLECULES 40 153 1.466e-07 2.75e-06
248 REGULATION OF RHO PROTEIN SIGNAL TRANSDUCTION 32 109 1.464e-07 2.75e-06
249 CELLULAR RESPONSE TO STEROID HORMONE STIMULUS 51 218 1.52e-07 2.84e-06
250 NEGATIVE REGULATION OF NITROGEN COMPOUND METABOLIC PROCESS 231 1517 1.591e-07 2.962e-06
251 PATTERN SPECIFICATION PROCESS 82 418 1.606e-07 2.976e-06
252 REGULATION OF MUSCLE SYSTEM PROCESS 47 195 1.805e-07 3.332e-06
253 REGULATION OF ION TRANSPORT 107 592 1.853e-07 3.408e-06
254 NEGATIVE REGULATION OF CELLULAR RESPONSE TO GROWTH FACTOR STIMULUS 34 121 1.946e-07 3.566e-06
255 AXIS ELONGATION 14 27 1.958e-07 3.573e-06
256 CEREBRAL CORTEX DEVELOPMENT 31 105 1.982e-07 3.603e-06
257 TRANSMEMBRANE RECEPTOR PROTEIN SERINE THREONINE KINASE SIGNALING PATHWAY 46 190 2.112e-07 3.824e-06
258 REGULATION OF PHOSPHATIDYLINOSITOL 3 KINASE SIGNALING 37 138 2.132e-07 3.845e-06
259 REGULATION OF STRESS ACTIVATED PROTEIN KINASE SIGNALING CASCADE 47 197 2.493e-07 4.479e-06
260 CARDIAC VENTRICLE DEVELOPMENT 31 106 2.507e-07 4.487e-06
261 REGULATION OF EXTENT OF CELL GROWTH 30 101 2.68e-07 4.779e-06
262 EPIDERMIS DEVELOPMENT 56 253 2.766e-07 4.913e-06
263 REGULATION OF CHEMOTAXIS 44 180 2.881e-07 5.097e-06
264 REGULATION OF GROWTH 112 633 2.955e-07 5.209e-06
265 ACTIVATION OF PROTEIN KINASE ACTIVITY 60 279 3.033e-07 5.326e-06
266 REGULATION OF HEART RATE 27 86 3.047e-07 5.33e-06
267 APPENDAGE DEVELOPMENT 42 169 3.289e-07 5.71e-06
268 LIMB DEVELOPMENT 42 169 3.289e-07 5.71e-06
269 NEGATIVE REGULATION OF TRANSMEMBRANE RECEPTOR PROTEIN SERINE THREONINE KINASE SIGNALING PATHWAY 30 102 3.399e-07 5.879e-06
270 NEGATIVE REGULATION OF GENE EXPRESSION 226 1493 3.499e-07 6.03e-06
271 NEGATIVE REGULATION OF MOLECULAR FUNCTION 172 1079 3.784e-07 6.497e-06
272 DEVELOPMENTAL CELL GROWTH 25 77 4.054e-07 6.936e-06
273 REGULATION OF ENDOTHELIAL CELL MIGRATION 32 114 4.52e-07 7.681e-06
274 MULTI MULTICELLULAR ORGANISM PROCESS 49 213 4.523e-07 7.681e-06
275 CELL MIGRATION INVOLVED IN SPROUTING ANGIOGENESIS 10 15 4.791e-07 8.106e-06
276 REGULATION OF NUCLEOCYTOPLASMIC TRANSPORT 50 220 5.121e-07 8.634e-06
277 CHEMICAL HOMEOSTASIS 144 874 5.238e-07 8.798e-06
278 SENSORY ORGAN MORPHOGENESIS 53 239 5.369e-07 8.986e-06
279 CARDIAC CHAMBER MORPHOGENESIS 30 104 5.4e-07 9.006e-06
280 CYTOSKELETON ORGANIZATION 139 838 5.633e-07 9.361e-06
281 REGULATION OF WNT SIGNALING PATHWAY 64 310 5.758e-07 9.534e-06
282 VASCULOGENESIS 21 59 6.077e-07 1.003e-05
283 NEGATIVE REGULATION OF PROTEIN METABOLIC PROCESS 172 1087 6.145e-07 1.01e-05
284 FORMATION OF PRIMARY GERM LAYER 31 110 6.181e-07 1.011e-05
285 LEUKOCYTE MIGRATION 56 259 6.191e-07 1.011e-05
286 REGULATION OF ADHERENS JUNCTION ORGANIZATION 19 50 6.478e-07 1.051e-05
287 HEMOSTASIS 64 311 6.48e-07 1.051e-05
288 EMBRYONIC ORGAN MORPHOGENESIS 59 279 6.857e-07 1.108e-05
289 PERIPHERAL NERVOUS SYSTEM DEVELOPMENT 23 69 6.906e-07 1.108e-05
290 SYNAPSE ASSEMBLY 23 69 6.906e-07 1.108e-05
291 DENDRITE DEVELOPMENT 25 79 7.002e-07 1.12e-05
292 CELL CELL ADHESION VIA PLASMA MEMBRANE ADHESION MOLECULES 47 204 7.356e-07 1.172e-05
293 RESPONSE TO ACID CHEMICAL 65 319 7.662e-07 1.217e-05
294 MUSCLE CELL DEVELOPMENT 34 128 8.255e-07 1.307e-05
295 STEM CELL PROLIFERATION 21 60 8.379e-07 1.316e-05
296 REGULATION OF CELL MATRIX ADHESION 27 90 8.401e-07 1.316e-05
297 ESTABLISHMENT OF PROTEIN LOCALIZATION TO PLASMA MEMBRANE 27 90 8.401e-07 1.316e-05
298 ION TRANSPORT 194 1262 8.86e-07 1.383e-05
299 CELLULAR RESPONSE TO ACID CHEMICAL 42 175 8.983e-07 1.393e-05
300 GLIOGENESIS 42 175 8.983e-07 1.393e-05
301 ARTERY DEVELOPMENT 24 75 9.267e-07 1.431e-05
302 REPRODUCTIVE SYSTEM DEVELOPMENT 78 408 9.288e-07 1.431e-05
303 RESPONSE TO KETONE 43 182 1.052e-06 1.615e-05
304 POSITIVE REGULATION OF CELL ADHESION 73 376 1.134e-06 1.736e-05
305 OSSIFICATION 54 251 1.148e-06 1.752e-05
306 METANEPHROS DEVELOPMENT 25 81 1.182e-06 1.797e-05
307 REGULATION OF JNK CASCADE 39 159 1.217e-06 1.844e-05
308 SKIN EPIDERMIS DEVELOPMENT 23 71 1.221e-06 1.845e-05
309 CELL DEATH 159 1001 1.317e-06 1.976e-05
310 REGULATION OF VASCULATURE DEVELOPMENT 51 233 1.317e-06 1.976e-05
311 PROSTATE GLAND MORPHOGENESIS 12 23 1.37e-06 2.049e-05
312 REGULATION OF CELLULAR PROTEIN LOCALIZATION 98 552 1.388e-06 2.07e-05
313 RHYTHMIC PROCESS 61 298 1.414e-06 2.101e-05
314 CELLULAR RESPONSE TO OXIDATIVE STRESS 43 184 1.435e-06 2.127e-05
315 REGULATION OF EMBRYONIC DEVELOPMENT 31 114 1.441e-06 2.128e-05
316 REGULATION OF METAL ION TRANSPORT 65 325 1.509e-06 2.221e-05
317 REGULATION OF RESPONSE TO WOUNDING 78 413 1.517e-06 2.227e-05
318 RESPONSE TO OXIDATIVE STRESS 69 352 1.549e-06 2.267e-05
319 PLASMA MEMBRANE ORGANIZATION 46 203 1.57e-06 2.283e-05
320 POSITIVE REGULATION OF CHEMOTAXIS 32 120 1.566e-06 2.283e-05
321 REGULATION OF RESPONSE TO STRESS 219 1468 1.588e-06 2.301e-05
322 REGULATION OF VESICLE MEDIATED TRANSPORT 85 462 1.596e-06 2.306e-05
323 REGULATION OF CATENIN IMPORT INTO NUCLEUS 13 27 1.611e-06 2.32e-05
324 RESPONSE TO REACTIVE OXYGEN SPECIES 44 191 1.645e-06 2.362e-05
325 NEGATIVE REGULATION OF RESPONSE TO EXTERNAL STIMULUS 57 274 1.82e-06 2.605e-05
326 REGULATION OF MORPHOGENESIS OF A BRANCHING STRUCTURE 19 53 1.828e-06 2.61e-05
327 ACTIN FILAMENT BASED PROCESS 83 450 1.903e-06 2.703e-05
328 CELL CELL SIGNALING 127 767 1.911e-06 2.703e-05
329 RESPONSE TO TRANSFORMING GROWTH FACTOR BETA 36 144 1.911e-06 2.703e-05
330 EPITHELIAL CELL DEVELOPMENT 43 186 1.946e-06 2.744e-05
331 REGULATION OF CANONICAL WNT SIGNALING PATHWAY 51 236 1.961e-06 2.757e-05
332 POSITIVE REGULATION OF DEVELOPMENTAL GROWTH 38 156 1.986e-06 2.784e-05
333 MODULATION OF SYNAPTIC TRANSMISSION 61 301 1.997e-06 2.791e-05
334 NEGATIVE REGULATION OF TRANSPORT 84 458 2.088e-06 2.909e-05
335 ASSOCIATIVE LEARNING 23 73 2.103e-06 2.921e-05
336 RESPONSE TO BMP 27 94 2.149e-06 2.968e-05
337 CELLULAR RESPONSE TO BMP STIMULUS 27 94 2.149e-06 2.968e-05
338 RESPONSE TO ESTROGEN 48 218 2.236e-06 3.078e-05
339 GLOMERULUS DEVELOPMENT 18 49 2.264e-06 3.108e-05
340 POSITIVE REGULATION OF PROTEIN SERINE THREONINE KINASE ACTIVITY 59 289 2.285e-06 3.127e-05
341 PROTEIN LOCALIZATION TO CELL PERIPHERY 37 151 2.318e-06 3.154e-05
342 CELLULAR RESPONSE TO ABIOTIC STIMULUS 55 263 2.315e-06 3.154e-05
343 DEVELOPMENTAL PROCESS INVOLVED IN REPRODUCTION 104 602 2.423e-06 3.287e-05
344 BLOOD VESSEL ENDOTHELIAL CELL MIGRATION 12 24 2.463e-06 3.331e-05
345 BRANCH ELONGATION OF AN EPITHELIUM 10 17 2.515e-06 3.382e-05
346 EMBRYONIC DIGESTIVE TRACT MORPHOGENESIS 10 17 2.515e-06 3.382e-05
347 HOMEOSTATIC PROCESS 201 1337 2.621e-06 3.514e-05
348 SALIVARY GLAND DEVELOPMENT 14 32 2.689e-06 3.585e-05
349 PATTERNING OF BLOOD VESSELS 14 32 2.689e-06 3.585e-05
350 LUNG MORPHOGENESIS 17 45 2.755e-06 3.652e-05
351 SMOOTH MUSCLE CONTRACTION 17 45 2.755e-06 3.652e-05
352 IN UTERO EMBRYONIC DEVELOPMENT 62 311 2.912e-06 3.849e-05
353 EAR DEVELOPMENT 44 195 2.954e-06 3.894e-05
354 CARDIAC SEPTUM DEVELOPMENT 25 85 3.159e-06 4.141e-05
355 PALATE DEVELOPMENT 25 85 3.159e-06 4.141e-05
356 NEGATIVE REGULATION OF FAT CELL DIFFERENTIATION 16 41 3.276e-06 4.282e-05
357 INOSITOL LIPID MEDIATED SIGNALING 32 124 3.375e-06 4.399e-05
358 REGULATION OF BIOMINERAL TISSUE DEVELOPMENT 23 75 3.534e-06 4.594e-05
359 RESPONSE TO METAL ION 65 333 3.568e-06 4.624e-05
360 CHONDROCYTE DIFFERENTIATION 20 60 3.633e-06 4.682e-05
361 POSITIVE REGULATION OF OSTEOBLAST DIFFERENTIATION 20 60 3.633e-06 4.682e-05
362 ENSHEATHMENT OF NEURONS 26 91 3.674e-06 4.709e-05
363 AXON ENSHEATHMENT 26 91 3.674e-06 4.709e-05
364 REGULATION OF PROTEIN LOCALIZATION 150 950 3.712e-06 4.745e-05
365 PLATELET ACTIVATION 35 142 3.73e-06 4.755e-05
366 CELL MATRIX ADHESION 31 119 3.861e-06 4.908e-05
367 EMBRYONIC DIGESTIVE TRACT DEVELOPMENT 14 33 4.195e-06 5.319e-05
368 EPITHELIAL TUBE BRANCHING INVOLVED IN LUNG MORPHOGENESIS 12 25 4.259e-06 5.37e-05
369 MEMBRANE ASSEMBLY 12 25 4.259e-06 5.37e-05
370 NEGATIVE REGULATION OF CELL ADHESION 48 223 4.351e-06 5.472e-05
371 GASTRULATION 37 155 4.479e-06 5.618e-05
372 REGULATION OF MUSCLE TISSUE DEVELOPMENT 28 103 4.601e-06 5.754e-05
373 REGULATION OF NEURON APOPTOTIC PROCESS 43 192 4.67e-06 5.825e-05
374 POSITIVE REGULATION OF MUSCLE TISSUE DEVELOPMENT 19 56 4.704e-06 5.853e-05
375 IMMUNE SYSTEM DEVELOPMENT 100 582 4.799e-06 5.954e-05
376 MESODERM MORPHOGENESIS 21 66 4.848e-06 6e-05
377 REGULATION OF TRANSMEMBRANE TRANSPORT 78 426 5.093e-06 6.286e-05
378 REGULATION OF ENDOTHELIAL CELL PROLIFERATION 27 98 5.14e-06 6.328e-05
379 CELLULAR RESPONSE TO INORGANIC SUBSTANCE 37 156 5.254e-06 6.451e-05
380 CELLULAR RESPONSE TO ALCOHOL 30 115 5.33e-06 6.526e-05
381 PROTEIN LOCALIZATION 258 1805 5.426e-06 6.595e-05
382 KIDNEY MORPHOGENESIS 24 82 5.428e-06 6.595e-05
383 CARDIAC CONDUCTION 24 82 5.428e-06 6.595e-05
384 WNT SIGNALING PATHWAY 67 351 5.606e-06 6.782e-05
385 POSITIVE REGULATION OF BIOMINERAL TISSUE DEVELOPMENT 15 38 5.611e-06 6.782e-05
386 CELLULAR RESPONSE TO REACTIVE OXYGEN SPECIES 28 104 5.638e-06 6.796e-05
387 POSITIVE REGULATION OF GROWTH 50 238 5.721e-06 6.861e-05
388 LOCOMOTORY BEHAVIOR 41 181 5.721e-06 6.861e-05
389 CELLULAR CHEMICAL HOMEOSTASIS 98 570 5.796e-06 6.932e-05
390 NEGATIVE REGULATION OF CATALYTIC ACTIVITY 133 829 5.881e-06 7.017e-05
391 POSITIVE REGULATION OF VASCULATURE DEVELOPMENT 33 133 5.994e-06 7.133e-05
392 ACTIVATION OF MAPKK ACTIVITY 18 52 6.037e-06 7.166e-05
393 REGULATION OF STEM CELL PROLIFERATION 25 88 6.277e-06 7.431e-05
394 ENDOTHELIAL CELL MIGRATION 19 57 6.329e-06 7.474e-05
395 PLATELET DERIVED GROWTH FACTOR RECEPTOR SIGNALING PATHWAY 14 34 6.407e-06 7.518e-05
396 REGULATION OF MESENCHYMAL CELL PROLIFERATION 14 34 6.407e-06 7.518e-05
397 POSITIVE REGULATION OF PHOSPHATIDYLINOSITOL 3 KINASE SIGNALING 20 62 6.415e-06 7.518e-05
398 REGULATION OF ION HOMEOSTASIS 44 201 6.805e-06 7.956e-05
399 MEMBRANE BIOGENESIS 13 30 6.981e-06 8.12e-05
400 SMOOTH MUSCLE CELL DIFFERENTIATION 13 30 6.981e-06 8.12e-05
401 ACTION POTENTIAL 26 94 7.062e-06 8.195e-05
402 REGULATION OF CELLULAR RESPONSE TO STRESS 114 691 7.588e-06 8.783e-05
403 POST EMBRYONIC DEVELOPMENT 25 89 7.82e-06 9.029e-05
404 POSITIVE REGULATION OF ENDOTHELIAL CELL PROLIFERATION 21 68 8.211e-06 9.457e-05
405 CELLULAR RESPONSE TO PEPTIDE 55 274 8.374e-06 9.621e-05
406 SIGNAL TRANSDUCTION BY PROTEIN PHOSPHORYLATION 74 404 8.688e-06 9.957e-05
407 DIVALENT INORGANIC CATION TRANSPORT 54 268 8.985e-06 0.0001027
408 SYSTEM PROCESS 254 1785 9.031e-06 0.000103
409 RESPIRATORY SYSTEM DEVELOPMENT 43 197 9.296e-06 0.0001056
410 MESODERM DEVELOPMENT 30 118 9.305e-06 0.0001056
411 REGULATION OF CELL GROWTH 72 391 9.469e-06 0.0001072
412 RESPONSE TO MECHANICAL STIMULUS 45 210 9.65e-06 0.000109
413 ENDOTHELIUM DEVELOPMENT 25 90 9.7e-06 0.000109
414 REGULATION OF GLIOGENESIS 25 90 9.7e-06 0.000109
415 GLIAL CELL DIFFERENTIATION 33 136 9.968e-06 0.0001118
416 CELL CELL JUNCTION ASSEMBLY 22 74 1.001e-05 0.0001119
417 PHOSPHATIDYLINOSITOL 3 PHOSPHATE BIOSYNTHETIC PROCESS 17 49 1.053e-05 0.0001172
418 CARDIAC CELL DEVELOPMENT 17 49 1.053e-05 0.0001172
419 IMMUNE SYSTEM PROCESS 278 1984 1.096e-05 0.0001216
420 SKIN DEVELOPMENT 45 211 1.097e-05 0.0001216
421 POSITIVE REGULATION OF TRANSCRIPTION FROM RNA POLYMERASE II PROMOTER INVOLVED IN CELLULAR RESPONSE TO CHEMICAL STIMULUS 12 27 1.151e-05 0.0001272
422 ORGANIC HYDROXY COMPOUND TRANSPORT 36 155 1.154e-05 0.0001273
423 REGULATION OF ERK1 AND ERK2 CASCADE 49 238 1.256e-05 0.0001382
424 ODONTOGENESIS OF DENTIN CONTAINING TOOTH 22 75 1.269e-05 0.0001393
425 ENDOMEMBRANE SYSTEM ORGANIZATION 82 465 1.276e-05 0.0001397
426 NEGATIVE REGULATION OF CELLULAR COMPONENT ORGANIZATION 112 684 1.283e-05 0.0001402
427 REGULATION OF MUSCLE ORGAN DEVELOPMENT 27 103 1.404e-05 0.000153
428 VISUAL BEHAVIOR 17 50 1.431e-05 0.0001556
429 CRANIAL SKELETAL SYSTEM DEVELOPMENT 18 55 1.472e-05 0.0001597
430 POSITIVE REGULATION OF MAP KINASE ACTIVITY 44 207 1.492e-05 0.0001615
431 SEX DIFFERENTIATION 53 266 1.506e-05 0.0001626
432 CELLULAR RESPONSE TO EXTRACELLULAR STIMULUS 41 188 1.517e-05 0.0001634
433 CELL FATE COMMITMENT 47 227 1.605e-05 0.0001724
434 PROSTATE GLAND DEVELOPMENT 15 41 1.666e-05 0.0001787
435 REGULATION OF SMOOTH MUSCLE CELL DIFFERENTIATION 10 20 1.745e-05 0.0001858
436 TRACHEA DEVELOPMENT 10 20 1.745e-05 0.0001858
437 AXONAL FASCICULATION 10 20 1.745e-05 0.0001858
438 REGULATION OF PROTEIN IMPORT 40 183 1.812e-05 0.0001921
439 POSITIVE REGULATION OF PHOSPHATASE ACTIVITY 12 28 1.812e-05 0.0001921
440 INTEGRIN MEDIATED SIGNALING PATHWAY 23 82 1.829e-05 0.0001934
441 POSITIVE REGULATION OF WNT SIGNALING PATHWAY 35 152 1.849e-05 0.0001951
442 REGULATION OF EPITHELIAL CELL DIFFERENTIATION 30 122 1.881e-05 0.000198
443 REGULATION OF CALCIUM ION TRANSPORT 44 209 1.918e-05 0.0002015
444 ARTERY MORPHOGENESIS 17 51 1.927e-05 0.0002019
445 LIPID PHOSPHORYLATION 26 99 1.94e-05 0.0002029
446 RESPONSE TO NERVE GROWTH FACTOR 14 37 2.039e-05 0.0002122
447 CELL COMMUNICATION INVOLVED IN CARDIAC CONDUCTION 14 37 2.039e-05 0.0002122
448 REGULATION OF EXTRINSIC APOPTOTIC SIGNALING PATHWAY 35 153 2.146e-05 0.0002229
449 REGULATION OF RECEPTOR ACTIVITY 29 117 2.191e-05 0.0002265
450 REGULATION OF MUSCLE CONTRACTION 34 147 2.19e-05 0.0002265
451 POSITIVE REGULATION OF STRESS ACTIVATED PROTEIN KINASE SIGNALING CASCADE 32 135 2.241e-05 0.0002312
452 GLYCEROPHOSPHOLIPID METABOLIC PROCESS 57 297 2.311e-05 0.0002379
453 NEGATIVE REGULATION OF KINASE ACTIVITY 50 250 2.334e-05 0.0002385
454 DENDRITE MORPHOGENESIS 15 42 2.328e-05 0.0002385
455 CENTRAL NERVOUS SYSTEM NEURON DIFFERENTIATION 37 166 2.338e-05 0.0002385
456 AUTONOMIC NERVOUS SYSTEM DEVELOPMENT 15 42 2.328e-05 0.0002385
457 REGULATION OF SMOOTH MUSCLE CELL PROLIFERATION 26 100 2.349e-05 0.0002392
458 NEURON RECOGNITION 13 33 2.427e-05 0.0002465
459 REGULATION OF CYTOSKELETON ORGANIZATION 86 502 2.432e-05 0.0002466
460 REGULATION OF FAT CELL DIFFERENTIATION 27 106 2.462e-05 0.0002491
461 RENAL TUBULE DEVELOPMENT 22 78 2.51e-05 0.0002533
462 REGULATION OF INTRACELLULAR PROTEIN TRANSPORT 69 381 2.525e-05 0.0002543
463 POSITIVE REGULATION OF CELL GROWTH 34 148 2.545e-05 0.0002558
464 MAMMARY GLAND ALVEOLUS DEVELOPMENT 9 17 2.591e-05 0.0002593
465 MAMMARY GLAND LOBULE DEVELOPMENT 9 17 2.591e-05 0.0002593
466 EYE MORPHOGENESIS 32 136 2.624e-05 0.000262
467 REGULATION OF ORGAN GROWTH 21 73 2.75e-05 0.000274
468 NEGATIVE REGULATION OF DEVELOPMENTAL GROWTH 23 84 2.799e-05 0.0002783
469 CAMERA TYPE EYE MORPHOGENESIS 26 101 2.834e-05 0.0002812
470 PHOSPHATIDYLINOSITOL METABOLIC PROCESS 41 193 2.912e-05 0.0002876
471 REGULATION OF NEURON DEATH 50 252 2.909e-05 0.0002876
472 RESPONSE TO PEPTIDE 72 404 2.951e-05 0.0002909
473 SYMPATHETIC NERVOUS SYSTEM DEVELOPMENT 10 21 3.001e-05 0.0002952
474 OVULATION CYCLE 28 113 3.031e-05 0.0002976
475 CALCIUM MEDIATED SIGNALING 24 90 3.046e-05 0.0002984
476 GLYCEROLIPID METABOLIC PROCESS 65 356 3.306e-05 0.0003224
477 ANTERIOR POSTERIOR PATTERN SPECIFICATION 41 194 3.303e-05 0.0003224
478 REGULATION OF SECRETION 112 699 3.358e-05 0.0003268
479 RESPONSE TO AXON INJURY 16 48 3.369e-05 0.0003272
480 MESONEPHRIC TUBULE MORPHOGENESIS 17 53 3.396e-05 0.0003292
481 REGULATION OF ACUTE INFLAMMATORY RESPONSE 21 74 3.443e-05 0.0003331
482 NEGATIVE REGULATION OF CELL PROJECTION ORGANIZATION 33 144 3.504e-05 0.0003382
483 RESPONSE TO FLUID SHEAR STRESS 13 34 3.532e-05 0.0003403
484 POSITIVE REGULATION OF ENDOCYTOSIS 28 114 3.599e-05 0.0003454
485 CRANIOFACIAL SUTURE MORPHOGENESIS 8 14 3.6e-05 0.0003454
486 NEGATIVE REGULATION OF MAPK CASCADE 33 145 4.061e-05 0.0003888
487 NEGATIVE REGULATION OF EPITHELIAL CELL PROLIFERATION 28 115 4.262e-05 0.0004072
488 POSITIVE REGULATION OF NUCLEOCYTOPLASMIC TRANSPORT 29 121 4.286e-05 0.0004086
489 VENTRICULAR SEPTUM DEVELOPMENT 17 54 4.449e-05 0.0004233
490 NEGATIVE REGULATION OF NEURON DEATH 37 171 4.619e-05 0.0004386
491 CALCIUM ION TRANSPORT 45 223 4.657e-05 0.0004413
492 RESPONSE TO ESTRADIOL 33 146 4.698e-05 0.0004439
493 NEGATIVE REGULATION OF EMBRYONIC DEVELOPMENT 11 26 4.703e-05 0.0004439
494 NEGATIVE REGULATION OF EXTRINSIC APOPTOTIC SIGNALING PATHWAY 25 98 4.72e-05 0.0004445
495 REGULATION OF JUN KINASE ACTIVITY 22 81 4.748e-05 0.0004463
496 INTERACTION WITH HOST 31 134 4.926e-05 0.0004621
497 NEURON MIGRATION 27 110 4.983e-05 0.0004665
498 REGULATION OF PHOSPHATASE ACTIVITY 30 128 4.998e-05 0.000467
499 MOVEMENT IN ENVIRONMENT OF OTHER ORGANISM INVOLVED IN SYMBIOTIC INTERACTION 23 87 5.129e-05 0.0004726
500 ENTRY INTO CELL OF OTHER ORGANISM INVOLVED IN SYMBIOTIC INTERACTION 23 87 5.129e-05 0.0004726
501 VIRAL ENTRY INTO HOST CELL 23 87 5.129e-05 0.0004726
502 ENTRY INTO OTHER ORGANISM INVOLVED IN SYMBIOTIC INTERACTION 23 87 5.129e-05 0.0004726
503 MOVEMENT IN HOST ENVIRONMENT 23 87 5.129e-05 0.0004726
504 ENTRY INTO HOST 23 87 5.129e-05 0.0004726
505 ENTRY INTO HOST CELL 23 87 5.129e-05 0.0004726
506 CELLULAR HOMEOSTASIS 108 676 5.21e-05 0.0004791
507 REGULATION OF TRANSPORTER ACTIVITY 41 198 5.401e-05 0.0004956
508 NEPHRON EPITHELIUM DEVELOPMENT 24 93 5.433e-05 0.0004976
509 POSITIVE REGULATION OF SMOOTH MUSCLE CELL PROLIFERATION 18 60 5.499e-05 0.0005027
510 POSITIVE REGULATION OF CELL SUBSTRATE ADHESION 25 99 5.659e-05 0.0005163
511 NEGATIVE REGULATION OF NEURON APOPTOTIC PROCESS 31 135 5.726e-05 0.0005214
512 EPIDERMAL GROWTH FACTOR RECEPTOR SIGNALING PATHWAY 17 55 5.781e-05 0.0005243
513 RESPONSE TO EXTRACELLULAR STIMULUS 76 441 5.774e-05 0.0005243
514 NEGATIVE REGULATION OF CELL MORPHOGENESIS INVOLVED IN DIFFERENTIATION 28 117 5.927e-05 0.0005355
515 MAMMARY GLAND DEVELOPMENT 28 117 5.927e-05 0.0005355
516 REGULATION OF HORMONE LEVELS 81 478 6.092e-05 0.0005477
517 REGULATION OF ENDOCYTOSIS 41 199 6.087e-05 0.0005477
518 REGULATION OF PROTEIN TARGETING 57 307 6.097e-05 0.0005477
519 ESTABLISHMENT OF CELL POLARITY 23 88 6.226e-05 0.0005565
520 POSITIVE REGULATION OF CELLULAR COMPONENT BIOGENESIS 71 406 6.231e-05 0.0005565
521 OVULATION CYCLE PROCESS 23 88 6.226e-05 0.0005565
522 REGULATION OF CARDIAC MUSCLE CONTRACTION 19 66 6.468e-05 0.0005755
523 REGULATION OF CARDIAC CONDUCTION 19 66 6.468e-05 0.0005755
524 REGULATION OF PEPTIDYL TYROSINE PHOSPHORYLATION 43 213 6.719e-05 0.0005959
525 DIVALENT INORGANIC CATION HOMEOSTASIS 62 343 6.723e-05 0.0005959
526 REGULATION OF PEPTIDYL SERINE PHOSPHORYLATION 28 118 6.962e-05 0.000615
527 VENOUS BLOOD VESSEL DEVELOPMENT 8 15 6.965e-05 0.000615
528 POSITIVE REGULATION OF STEM CELL PROLIFERATION 18 61 7.002e-05 0.000617
529 HAIR CYCLE 22 83 7.098e-05 0.0006232
530 MOLTING CYCLE 22 83 7.098e-05 0.0006232
531 POSITIVE REGULATION OF MESENCHYMAL CELL PROLIFERATION 11 27 7.145e-05 0.0006261
532 REPRODUCTION 187 1297 7.158e-05 0.0006261
533 CELLULAR RESPONSE TO OXYGEN LEVELS 32 143 7.452e-05 0.0006505
534 CELL CHEMOTAXIS 35 162 7.549e-05 0.0006578
535 LUNG ALVEOLUS DEVELOPMENT 14 41 7.674e-05 0.0006674
536 NEGATIVE REGULATION OF RESPONSE TO WOUNDING 34 156 7.907e-05 0.0006864
537 REGULATION OF RECEPTOR MEDIATED ENDOCYTOSIS 21 78 8.043e-05 0.0006962
538 STEROID HORMONE MEDIATED SIGNALING PATHWAY 29 125 8.049e-05 0.0006962
539 REGULATION OF CATION TRANSMEMBRANE TRANSPORT 42 208 8.072e-05 0.0006968
540 VASCULAR PROCESS IN CIRCULATORY SYSTEM 35 163 8.606e-05 0.0007416
541 POSITIVE REGULATION OF MUSCLE CELL DIFFERENTIATION 22 84 8.623e-05 0.0007417
542 FOREBRAIN CELL MIGRATION 18 62 8.856e-05 0.0007575
543 NEGATIVE REGULATION OF SYNAPTIC TRANSMISSION 18 62 8.856e-05 0.0007575
544 CARDIAC VENTRICLE MORPHOGENESIS 18 62 8.856e-05 0.0007575
545 REGULATION OF WOUND HEALING 29 126 9.366e-05 0.0007997
546 HEMIDESMOSOME ASSEMBLY 7 12 9.617e-05 0.000818
547 POSITIVE REGULATION OF CATENIN IMPORT INTO NUCLEUS 7 12 9.617e-05 0.000818
548 REGULATION OF RECEPTOR INTERNALIZATION 13 37 9.86e-05 0.0008341
549 ERBB SIGNALING PATHWAY 21 79 9.826e-05 0.0008341
550 CARDIAC MUSCLE CELL ACTION POTENTIAL 13 37 9.86e-05 0.0008341
551 LIPID LOCALIZATION 50 264 0.0001007 0.0008505
552 REGULATION OF CELL SHAPE 31 139 0.0001024 0.0008628
553 GENITALIA DEVELOPMENT 14 42 0.0001035 0.0008705
554 METAL ION TRANSPORT 94 582 0.0001045 0.0008755
555 LEUKOCYTE DIFFERENTIATION 54 292 0.0001046 0.0008755
556 HEART PROCESS 22 85 0.0001043 0.0008755
557 REGULATION OF CARTILAGE DEVELOPMENT 18 63 0.0001113 0.0009296
558 RESPONSE TO HYDROGEN PEROXIDE 26 109 0.0001135 0.0009462
559 PHOSPHOLIPID METABOLIC PROCESS 64 364 0.0001194 0.0009938
560 EMBRYONIC PATTERN SPECIFICATION 17 58 0.0001211 0.001006
561 AXON REGENERATION 10 24 0.000122 0.001012
562 NEGATIVE REGULATION OF JNK CASCADE 12 33 0.0001246 0.001031
563 NEURON CELL CELL ADHESION 8 16 0.0001258 0.001036
564 RETINA VASCULATURE DEVELOPMENT IN CAMERA TYPE EYE 8 16 0.0001258 0.001036
565 BRANCHING INVOLVED IN SALIVARY GLAND MORPHOGENESIS 8 16 0.0001258 0.001036
566 MEMBRANE ORGANIZATION 135 899 0.000126 0.001036
567 AMINOGLYCAN METABOLIC PROCESS 35 166 0.0001263 0.001036
568 NEURON PROJECTION EXTENSION 16 53 0.0001296 0.001062
569 MELANOCYTE DIFFERENTIATION 9 20 0.0001313 0.001074
570 ESTABLISHMENT OR MAINTENANCE OF CELL POLARITY 31 141 0.0001352 0.001104
571 REGULATION OF CARDIAC MUSCLE TISSUE DEVELOPMENT 15 48 0.0001356 0.001105
572 SMALL GTPASE MEDIATED SIGNAL TRANSDUCTION 62 352 0.0001437 0.001169
573 POSITIVE REGULATION OF CYTOPLASMIC TRANSPORT 52 282 0.0001499 0.001217
574 EPIDERMIS MORPHOGENESIS 11 29 0.0001537 0.001237
575 POSITIVE REGULATION OF CELLULAR PROTEIN LOCALIZATION 63 360 0.000154 0.001237
576 STEM CELL DIVISION 11 29 0.0001537 0.001237
577 REGULATION OF HEART MORPHOGENESIS 11 29 0.0001537 0.001237
578 MUSCLE ORGAN MORPHOGENESIS 19 70 0.0001539 0.001237
579 POSITIVE REGULATION OF CARTILAGE DEVELOPMENT 11 29 0.0001537 0.001237
580 COLUMNAR CUBOIDAL EPITHELIAL CELL DIFFERENTIATION 26 111 0.0001559 0.00125
581 REGULATION OF TRANSFORMING GROWTH FACTOR BETA RECEPTOR SIGNALING PATHWAY 24 99 0.0001569 0.001254
582 REGULATION OF CELLULAR RESPONSE TO TRANSFORMING GROWTH FACTOR BETA STIMULUS 24 99 0.0001569 0.001254
583 SKELETAL SYSTEM MORPHOGENESIS 40 201 0.0001632 0.001303
584 REGULATION OF BINDING 52 283 0.0001643 0.001309
585 REGULATION OF SMOOTH MUSCLE CELL MIGRATION 15 49 0.0001757 0.001397
586 SINGLE ORGANISM CELLULAR LOCALIZATION 134 898 0.0001766 0.001402
587 CELL ACTIVATION 91 568 0.0001785 0.001415
588 REGULATION OF AXON GUIDANCE 13 39 0.0001818 0.001432
589 BRANCHING INVOLVED IN URETERIC BUD MORPHOGENESIS 14 44 0.0001818 0.001432
590 NEGATIVE REGULATION OF JAK STAT CASCADE 14 44 0.0001818 0.001432
591 NEGATIVE REGULATION OF STAT CASCADE 14 44 0.0001818 0.001432
592 REGULATION OF FIBROBLAST GROWTH FACTOR RECEPTOR SIGNALING PATHWAY 10 25 0.0001833 0.001441
593 ION HOMEOSTASIS 92 576 0.0001839 0.001443
594 SKELETAL MUSCLE ORGAN DEVELOPMENT 30 137 0.0001854 0.001452
595 PATHWAY RESTRICTED SMAD PROTEIN PHOSPHORYLATION 7 13 0.0001884 0.001467
596 REGULATION OF CELL COMMUNICATION BY ELECTRICAL COUPLING 7 13 0.0001884 0.001467
597 MESENCHYMAL CELL PROLIFERATION 7 13 0.0001884 0.001467
598 ADHERENS JUNCTION ORGANIZATION 19 71 0.0001886 0.001467
599 OLIGODENDROCYTE DIFFERENTIATION 17 60 0.0001914 0.001487
600 CELLULAR MACROMOLECULE LOCALIZATION 176 1234 0.0002052 0.001592
601 CHONDROCYTE DEVELOPMENT 9 21 0.0002072 0.001605
602 REGULATION OF KIDNEY DEVELOPMENT 16 55 0.0002095 0.00162
603 PROTEIN DEPHOSPHORYLATION 38 190 0.0002111 0.001629
604 NEGATIVE REGULATION OF CELLULAR RESPONSE TO TRANSFORMING GROWTH FACTOR BETA STIMULUS 18 66 0.000213 0.001638
605 NEGATIVE REGULATION OF TRANSFORMING GROWTH FACTOR BETA RECEPTOR SIGNALING PATHWAY 18 66 0.000213 0.001638
606 CYCLIC NUCLEOTIDE CATABOLIC PROCESS 8 17 0.0002145 0.001643
607 SEGMENTATION 22 89 0.000215 0.001643
608 NEGATIVE REGULATION OF ANOIKIS 8 17 0.0002145 0.001643
609 EPITHELIAL CELL PROLIFERATION 22 89 0.000215 0.001643
610 AMINOGLYCAN BIOSYNTHETIC PROCESS 25 107 0.0002156 0.001645
611 TRANSFORMING GROWTH FACTOR BETA RECEPTOR SIGNALING PATHWAY 23 95 0.0002176 0.001657
612 OSTEOCLAST DIFFERENTIATION 11 30 0.0002186 0.001662
613 ORGANIC HYDROXY COMPOUND METABOLIC PROCESS 79 482 0.0002256 0.001713
614 ENDOTHELIAL CELL DIFFERENTIATION 19 72 0.00023 0.001743
615 HORMONE MEDIATED SIGNALING PATHWAY 33 158 0.0002335 0.001766
616 RESPONSE TO MINERALOCORTICOID 12 35 0.0002373 0.001792
617 REGULATION OF PROTEIN LOCALIZATION TO NUCLEUS 42 218 0.0002379 0.001794
618 CELLULAR RESPONSE TO HYDROGEN PEROXIDE 17 61 0.0002383 0.001794
619 REGULATION OF DENDRITE DEVELOPMENT 27 120 0.0002389 0.001796
620 CELLULAR LIPID METABOLIC PROCESS 135 913 0.0002495 0.001872
621 VESICLE MEDIATED TRANSPORT 176 1239 0.0002519 0.001884
622 MUCOPOLYSACCHARIDE METABOLIC PROCESS 25 108 0.0002515 0.001884
623 CELLULAR RESPONSE TO INSULIN STIMULUS 31 146 0.000262 0.001957
624 EPITHELIAL TO MESENCHYMAL TRANSITION 16 56 0.0002636 0.001962
625 OUTFLOW TRACT MORPHOGENESIS 16 56 0.0002636 0.001962
626 POSITIVE REGULATION OF BINDING 28 127 0.0002653 0.001972
627 MESODERMAL CELL DIFFERENTIATION 10 26 0.0002684 0.001986
628 RESPONSE TO CORTICOSTERONE 10 26 0.0002684 0.001986
629 HEART GROWTH 10 26 0.0002684 0.001986
630 REGULATION OF PROTEIN KINASE B SIGNALING 27 121 0.0002756 0.002036
631 REGULATION OF LIPID METABOLIC PROCESS 51 282 0.000281 0.002072
632 HOMOTYPIC CELL CELL ADHESION 15 51 0.0002871 0.002114
633 MULTICELLULAR ORGANISM REPRODUCTION 116 768 0.0002942 0.002162
634 REGULATION OF CHONDROCYTE DIFFERENTIATION 14 46 0.0003067 0.002251
635 CENTRAL NERVOUS SYSTEM PROJECTION NEURON AXONOGENESIS 9 22 0.0003164 0.002311
636 SOMATIC STEM CELL DIVISION 9 22 0.0003164 0.002311
637 MONOAMINE TRANSPORT 9 22 0.0003164 0.002311
638 REGULATION OF MEMBRANE DEPOLARIZATION 13 41 0.0003192 0.002318
639 NEGATIVE REGULATION OF STRESS ACTIVATED MAPK CASCADE 13 41 0.0003192 0.002318
640 POSITIVE REGULATION OF AXON EXTENSION 12 36 0.0003204 0.002318
641 NEGATIVE REGULATION OF STRESS ACTIVATED PROTEIN KINASE SIGNALING CASCADE 13 41 0.0003192 0.002318
642 SEMAPHORIN PLEXIN SIGNALING PATHWAY 12 36 0.0003204 0.002318
643 POSITIVE CHEMOTAXIS 12 36 0.0003204 0.002318
644 CYCLIC NUCLEOTIDE METABOLIC PROCESS 16 57 0.0003292 0.002371
645 REGULATION OF CALCIUM ION TRANSMEMBRANE TRANSPORT 26 116 0.0003291 0.002371
646 FEMALE SEX DIFFERENTIATION 26 116 0.0003291 0.002371
647 ADULT BEHAVIOR 29 135 0.0003316 0.002385
648 POSITIVE REGULATION OF SYNAPTIC TRANSMISSION 25 110 0.0003395 0.002437
649 CAMP CATABOLIC PROCESS 7 14 0.0003408 0.00244
650 RESPONSE TO LAMINAR FLUID SHEAR STRESS 7 14 0.0003408 0.00244
651 REGULATION OF COLLATERAL SPROUTING 8 18 0.0003488 0.002474
652 REGULATION OF REPRODUCTIVE PROCESS 28 129 0.0003483 0.002474
653 PERICARDIUM DEVELOPMENT 8 18 0.0003488 0.002474
654 POSITIVE REGULATION OF PROTEIN IMPORT 24 104 0.0003478 0.002474
655 INOSITOL PHOSPHATE MEDIATED SIGNALING 8 18 0.0003488 0.002474
656 CELLULAR RESPONSE TO MECHANICAL STIMULUS 20 80 0.0003485 0.002474
657 MEMORY 23 98 0.0003535 0.002504
658 POSITIVE REGULATION OF REPRODUCTIVE PROCESS 15 52 0.0003627 0.002554
659 NEUROEPITHELIAL CELL DIFFERENTIATION 17 63 0.0003628 0.002554
660 REGULATION OF MUSCLE ADAPTATION 17 63 0.0003628 0.002554
661 RESPONSE TO OSMOTIC STRESS 17 63 0.0003628 0.002554
662 POSITIVE REGULATION OF ION TRANSPORT 44 236 0.0003634 0.002555
663 SECRETION 92 588 0.0003763 0.00264
664 NEGATIVE REGULATION OF CANONICAL WNT SIGNALING PATHWAY 33 162 0.0003773 0.00264
665 POSITIVE REGULATION OF RESPONSE TO WOUNDING 33 162 0.0003773 0.00264
666 REGULATION OF IMMUNE SYSTEM PROCESS 195 1403 0.0003791 0.002649
667 REGULATION OF CARDIAC MUSCLE CELL CONTRACTION 10 27 0.0003843 0.002673
668 HIPPO SIGNALING 10 27 0.0003843 0.002673
669 NEGATIVE REGULATION OF AXON GUIDANCE 10 27 0.0003843 0.002673
670 MYELOID CELL DIFFERENTIATION 37 189 0.0003931 0.00273
671 TRANSMEMBRANE TRANSPORT 157 1098 4e-04 0.002774
672 POSITIVE REGULATION OF AUTOPHAGY 19 75 0.0004052 0.002801
673 MULTI ORGANISM BEHAVIOR 19 75 0.0004052 0.002801
674 CELLULAR RESPONSE TO CORTICOSTEROID STIMULUS 16 58 0.0004085 0.00282
675 MYELOID LEUKOCYTE MIGRATION 23 99 0.000413 0.002847
676 POSITIVE REGULATION OF PROTEIN KINASE B SIGNALING 20 81 0.0004153 0.002854
677 EPITHELIAL CELL MORPHOGENESIS 13 42 0.0004159 0.002854
678 REGULATION OF HEART GROWTH 13 42 0.0004159 0.002854
679 ENDOCARDIAL CUSHION DEVELOPMENT 11 32 0.0004188 0.002862
680 REGULATION OF ORGAN FORMATION 11 32 0.0004188 0.002862
681 REGULATION OF ACTIN FILAMENT BASED MOVEMENT 11 32 0.0004188 0.002862
682 MATING 12 37 0.0004268 0.002908
683 AXON EXTENSION 12 37 0.0004268 0.002908
684 CIRCADIAN RHYTHM 29 137 0.0004293 0.002916
685 HINDBRAIN DEVELOPMENT 29 137 0.0004293 0.002916
686 REGULATION OF CELL CYCLE 138 949 0.0004402 0.002985
687 NEGATIVE REGULATION OF CELL GROWTH 34 170 0.000442 0.002994
688 REGULATION OF CARDIAC MUSCLE CONTRACTION BY CALCIUM ION SIGNALING 9 23 0.000469 0.003158
689 FAT CELL DIFFERENTIATION 24 106 0.0004687 0.003158
690 CENTRAL NERVOUS SYSTEM NEURON DEVELOPMENT 18 70 0.0004689 0.003158
691 REGULATION OF CALCIUM ION TRANSMEMBRANE TRANSPORTER ACTIVITY 18 70 0.0004689 0.003158
692 NEGATIVE REGULATION OF HYDROLASE ACTIVITY 66 397 0.0004812 0.003226
693 POSITIVE REGULATION OF TRANSMEMBRANE RECEPTOR PROTEIN SERINE THREONINE KINASE SIGNALING PATHWAY 23 100 0.0004811 0.003226
694 LIMBIC SYSTEM DEVELOPMENT 23 100 0.0004811 0.003226
695 REGULATION OF CATION CHANNEL ACTIVITY 21 88 0.0004943 0.00331
696 REGULATION OF MYOBLAST DIFFERENTIATION 14 48 0.0004987 0.003334
697 REGULATION OF GLIAL CELL DIFFERENTIATION 16 59 0.0005036 0.003362
698 REGULATION OF DEPHOSPHORYLATION 32 158 0.00051 0.0034
699 POSITIVE REGULATION OF ENDOTHELIAL CELL CHEMOTAXIS 6 11 0.0005139 0.003416
700 REGULATION OF FEVER GENERATION 6 11 0.0005139 0.003416
701 MAINTENANCE OF CELL NUMBER 28 132 0.0005158 0.003424
702 REGULATION OF STEM CELL DIFFERENTIATION 25 113 0.0005221 0.00346
703 CRANIAL NERVE DEVELOPMENT 13 43 0.0005364 0.00355
704 POSITIVE REGULATION OF ACUTE INFLAMMATORY RESPONSE 10 28 0.000539 0.003552
705 REGULATION OF NEUROBLAST PROLIFERATION 10 28 0.000539 0.003552
706 METANEPHROS MORPHOGENESIS 10 28 0.000539 0.003552
707 OSTEOBLAST DIFFERENTIATION 27 126 0.0005445 0.003573
708 MUSCLE CELL PROLIFERATION 8 19 0.0005443 0.003573
709 REGULATION OF CARDIAC MUSCLE CELL ACTION POTENTIAL 8 19 0.0005443 0.003573
710 REGULATION OF ORGANELLE ORGANIZATION 166 1178 0.0005477 0.00359
711 COLLAGEN FIBRIL ORGANIZATION 12 38 0.0005616 0.00367
712 REGULATION OF ACTION POTENTIAL 12 38 0.0005616 0.00367
713 NEURON PROJECTION REGENERATION 11 33 0.000566 0.003688
714 POSITIVE REGULATION OF EMBRYONIC DEVELOPMENT 11 33 0.000566 0.003688
715 CALCIUM ION TRANSMEMBRANE TRANSPORT 32 159 0.000572 0.003722
716 OLFACTORY BULB INTERNEURON DIFFERENTIATION 7 15 0.0005781 0.003726
717 OTIC VESICLE DEVELOPMENT 7 15 0.0005781 0.003726
718 REGULATION OF HEAT GENERATION 7 15 0.0005781 0.003726
719 REGULATION OF EPITHELIAL CELL DIFFERENTIATION INVOLVED IN KIDNEY DEVELOPMENT 7 15 0.0005781 0.003726
720 MORPHOGENESIS OF AN EPITHELIAL FOLD 7 15 0.0005781 0.003726
721 DIENCEPHALON DEVELOPMENT 19 77 0.000578 0.003726
722 STRIATED MUSCLE CELL PROLIFERATION 7 15 0.0005781 0.003726
723 POST GOLGI VESICLE MEDIATED TRANSPORT 20 83 0.000583 0.003752
724 MATERNAL PROCESS INVOLVED IN FEMALE PREGNANCY 16 60 0.0006171 0.003966
725 CELLULAR RESPONSE TO CALCIUM ION 14 49 0.000628 0.00403
726 PHOSPHOLIPID BIOSYNTHETIC PROCESS 43 235 0.0006315 0.004047
727 LIPID METABOLIC PROCESS 163 1158 0.0006452 0.004129
728 RENAL SYSTEM PROCESS 23 102 0.0006472 0.004137
729 REGULATION OF VASOCONSTRICTION 17 66 0.0006531 0.004169
730 RESPONSE TO CYTOKINE 107 714 0.0006597 0.004205
731 RESPONSE TO MOLECULE OF BACTERIAL ORIGIN 55 321 0.0006606 0.004205
732 MYELOID LEUKOCYTE DIFFERENTIATION 22 96 0.0006659 0.004233
733 REGULATION OF SEQUENCE SPECIFIC DNA BINDING TRANSCRIPTION FACTOR ACTIVITY 61 365 0.0006727 0.00427
734 REGULATION OF POSITIVE CHEMOTAXIS 9 24 0.0006772 0.004276
735 REGULATION OF ODONTOGENESIS 9 24 0.0006772 0.004276
736 REGULATION OF ANOIKIS 9 24 0.0006772 0.004276
737 CARDIAC EPITHELIAL TO MESENCHYMAL TRANSITION 9 24 0.0006772 0.004276
738 ANION TRANSPORT 80 507 0.0006807 0.004292
739 REGULATION OF CELL CELL ADHESION 63 380 0.0006864 0.00432
740 RESPONSE TO CALCIUM ION 25 115 0.0006871 0.00432
741 NEGATIVE REGULATION OF GROWTH 43 236 0.0006912 0.00434
742 REGULATION OF POSTSYNAPTIC MEMBRANE POTENTIAL 15 55 0.0006996 0.004387
743 MEMBRANE DEPOLARIZATION DURING ACTION POTENTIAL 12 39 0.0007304 0.004562
744 ASTROCYTE DIFFERENTIATION 12 39 0.0007304 0.004562
745 POSITIVE REGULATION OF SMALL GTPASE MEDIATED SIGNAL TRANSDUCTION 12 39 0.0007304 0.004562
746 REGULATION OF CARDIAC MUSCLE CELL PROLIFERATION 10 29 0.0007417 0.00462
747 CARDIAC MUSCLE CELL CONTRACTION 10 29 0.0007417 0.00462
748 EMBRYONIC SKELETAL SYSTEM DEVELOPMENT 26 122 0.0007451 0.004635
749 REGULATION OF PEPTIDE SECRETION 39 209 0.0007467 0.004638
750 MEMBRANE DEPOLARIZATION 16 61 0.0007518 0.004664
751 CAMP METABOLIC PROCESS 11 34 0.0007538 0.00467
752 HOMEOSTASIS OF NUMBER OF CELLS 34 175 0.0007612 0.00471
753 REGULATION OF SYNAPTIC TRANSMISSION GLUTAMATERGIC 14 50 0.0007845 0.004835
754 POSITIVE REGULATION OF STEM CELL DIFFERENTIATION 14 50 0.0007845 0.004835
755 PURINE CONTAINING COMPOUND CATABOLIC PROCESS 14 50 0.0007845 0.004835
756 POSITIVE REGULATION OF PEPTIDYL TYROSINE PHOSPHORYLATION 32 162 0.0007997 0.004922
757 CELLULAR RESPONSE TO KETONE 18 73 0.0008052 0.004943
758 REGULATION OF NEURAL PRECURSOR CELL PROLIFERATION 18 73 0.0008052 0.004943
759 REGULATION OF STRIATED MUSCLE CONTRACTION 19 79 0.0008111 0.004966
760 BONE MORPHOGENESIS 19 79 0.0008111 0.004966
761 REGULATION OF CYTOSOLIC CALCIUM ION CONCENTRATION 38 203 0.0008144 0.004973
762 GLYCOPROTEIN METABOLIC PROCESS 59 353 0.0008139 0.004973
763 EMBRYONIC HEMOPOIESIS 8 20 0.0008196 0.004985
764 RELAXATION OF MUSCLE 8 20 0.0008196 0.004985
765 LYMPH VESSEL DEVELOPMENT 8 20 0.0008196 0.004985
766 AMMONIUM ION METABOLIC PROCESS 33 169 0.0008242 0.005
767 REGULATION OF BLOOD PRESSURE 33 169 0.0008242 0.005
768 SMAD PROTEIN SIGNAL TRANSDUCTION 15 56 0.0008592 0.005199
769 RESPONSE TO RADIATION 67 413 0.0008588 0.005199
770 THYMOCYTE AGGREGATION 13 45 0.000867 0.005219
771 VENTRICULAR CARDIAC MUSCLE TISSUE DEVELOPMENT 13 45 0.000867 0.005219
772 POSITIVE REGULATION OF RECEPTOR ACTIVITY 13 45 0.000867 0.005219
773 T CELL DIFFERENTIATION IN THYMUS 13 45 0.000867 0.005219
774 RAS PROTEIN SIGNAL TRANSDUCTION 29 143 0.0008907 0.005348
775 NEGATIVE REGULATION OF INTRACELLULAR TRANSPORT 29 143 0.0008907 0.005348
776 SOMITOGENESIS 16 62 0.0009108 0.005461
777 NEURON PROJECTION EXTENSION INVOLVED IN NEURON PROJECTION GUIDANCE 6 12 0.0009317 0.005543
778 AXON EXTENSION INVOLVED IN AXON GUIDANCE 6 12 0.0009317 0.005543
779 REGULATION OF CLATHRIN MEDIATED ENDOCYTOSIS 7 16 0.0009299 0.005543
780 VASCULAR SMOOTH MUSCLE CONTRACTION 6 12 0.0009317 0.005543
781 TRACHEA MORPHOGENESIS 6 12 0.0009317 0.005543
782 REGIONALIZATION 53 311 0.0009293 0.005543
783 NEGATIVE REGULATION OF SMALL GTPASE MEDIATED SIGNAL TRANSDUCTION 12 40 0.0009395 0.005583
784 NERVE DEVELOPMENT 17 68 0.0009419 0.00559
785 ADULT LOCOMOTORY BEHAVIOR 19 80 0.0009552 0.005648
786 POSITIVE REGULATION OF INTRACELLULAR TRANSPORT 61 370 0.0009533 0.005648
787 REGULATION OF RELEASE OF SEQUESTERED CALCIUM ION INTO CYTOSOL BY SARCOPLASMIC RETICULUM 9 25 0.0009551 0.005648
788 MONOCARBOXYLIC ACID TRANSPORT 26 124 0.0009612 0.005676
789 RESPONSE TO INSULIN 38 205 0.0009853 0.00581
790 NEGATIVE REGULATION OF MUSCLE CELL APOPTOTIC PROCESS 10 30 0.001003 0.005872
791 NEGATIVE REGULATION OF INTRACELLULAR STEROID HORMONE RECEPTOR SIGNALING PATHWAY 10 30 0.001003 0.005872
792 REGULATION OF NEURON MIGRATION 10 30 0.001003 0.005872
793 POSITIVE REGULATION OF SMOOTH MUSCLE CELL MIGRATION 10 30 0.001003 0.005872
794 REGULATION OF HEART RATE BY CARDIAC CONDUCTION 10 30 0.001003 0.005872
795 REGULATION OF DENDRITIC SPINE MORPHOGENESIS 10 30 0.001003 0.005872
796 POSITIVE REGULATION OF LEUKOCYTE DIFFERENTIATION 27 131 0.00102 0.005957
797 RETINA DEVELOPMENT IN CAMERA TYPE EYE 27 131 0.00102 0.005957
798 AMMONIUM TRANSPORT 15 57 0.001048 0.006106
799 MYOTUBE DIFFERENTIATION 15 57 0.001048 0.006106
800 EAR MORPHOGENESIS 24 112 0.001077 0.006257
801 RESPONSE TO AMINO ACID 24 112 0.001077 0.006257
802 PEPTIDYL THREONINE MODIFICATION 13 46 0.001088 0.006295
803 CYCLIC NUCLEOTIDE MEDIATED SIGNALING 13 46 0.001088 0.006295
804 EMBRYONIC CRANIAL SKELETON MORPHOGENESIS 13 46 0.001088 0.006295
805 NEGATIVE REGULATION OF IMMUNE SYSTEM PROCESS 61 372 0.001092 0.006312
806 CELLULAR RESPONSE TO STRESS 211 1565 0.001108 0.006396
807 PHENOL CONTAINING COMPOUND METABOLIC PROCESS 19 81 0.001121 0.006461
808 NEGATIVE REGULATION OF OSSIFICATION 17 69 0.001123 0.006467
809 POSITIVE REGULATION OF ERK1 AND ERK2 CASCADE 33 172 0.001128 0.006486
810 CATION TRANSPORT 116 796 0.001132 0.006501
811 REGULATION OF PEPTIDE TRANSPORT 45 256 0.001143 0.006558
812 NEGATIVE REGULATION OF APOPTOTIC SIGNALING PATHWAY 37 200 0.001182 0.006776
813 PEPTIDYL TYROSINE DEPHOSPHORYLATION 22 100 0.001187 0.006792
814 ENDOCYTOSIS 79 509 0.001189 0.006797
815 METANEPHRIC NEPHRON MORPHOGENESIS 8 21 0.001196 0.006822
816 POSITIVE REGULATION OF NEUROBLAST PROLIFERATION 8 21 0.001196 0.006822
817 NEGATIVE REGULATION OF PROTEIN SERINE THREONINE KINASE ACTIVITY 26 126 0.00123 0.007003
818 ION TRANSMEMBRANE TRANSPORT 119 822 0.001251 0.007114
819 NEGATIVE REGULATION OF WOUND HEALING 15 58 0.001272 0.007225
820 POSITIVE REGULATION OF PEPTIDYL SERINE PHOSPHORYLATION 20 88 0.001277 0.007249
821 NEUROMUSCULAR JUNCTION DEVELOPMENT 11 36 0.001285 0.007259
822 OLFACTORY LOBE DEVELOPMENT 11 36 0.001285 0.007259
823 CORTICAL CYTOSKELETON ORGANIZATION 11 36 0.001285 0.007259
824 HEAD MORPHOGENESIS 11 36 0.001285 0.007259
825 PLATELET DEGRANULATION 23 107 0.001295 0.007306
826 MULTICELLULAR ORGANISMAL HOMEOSTASIS 47 272 0.001305 0.007351
827 REGULATION OF PHOSPHOLIPASE ACTIVITY 16 64 0.001315 0.007391
828 REGULATION OF NEUROTRANSMITTER TRANSPORT 16 64 0.001315 0.007391
829 GOLGI TO PLASMA MEMBRANE PROTEIN TRANSPORT 9 26 0.001319 0.007392
830 REGULATION OF CELL FATE COMMITMENT 9 26 0.001319 0.007392
831 LYSOSOMAL TRANSPORT 17 70 0.001333 0.007429
832 REGULATION OF CALCIUM MEDIATED SIGNALING 18 76 0.00133 0.007429
833 GLIAL CELL DEVELOPMENT 18 76 0.00133 0.007429
834 NEURAL PRECURSOR CELL PROLIFERATION 17 70 0.001333 0.007429
835 REGULATION OF INFLAMMATORY RESPONSE 50 294 0.001333 0.007429
836 MATERNAL PLACENTA DEVELOPMENT 10 31 0.001336 0.007434
837 POSITIVE REGULATION OF RECEPTOR MEDIATED ENDOCYTOSIS 13 47 0.001353 0.007515
838 POSITIVE REGULATION OF DEPHOSPHORYLATION 13 47 0.001353 0.007515
839 REGULATION OF ENDOTHELIAL CELL CHEMOTAXIS 7 17 0.001431 0.007935
840 RESPONSE TO STARVATION 30 154 0.001441 0.007979
841 POSITIVE REGULATION OF PHOSPHOLIPASE ACTIVITY 14 53 0.001464 0.0081
842 REGENERATION 31 161 0.001475 0.008151
843 INTRACELLULAR RECEPTOR SIGNALING PATHWAY 32 168 0.001503 0.008295
844 NEGATIVE REGULATION OF BMP SIGNALING PATHWAY 12 42 0.001508 0.008315
845 REGULATION OF BMP SIGNALING PATHWAY 18 77 0.001559 0.008585
846 RELAXATION OF CARDIAC MUSCLE 6 13 0.001569 0.008587
847 PERIPHERAL NERVOUS SYSTEM NEURON DIFFERENTIATION 6 13 0.001569 0.008587
848 CARDIOBLAST DIFFERENTIATION 6 13 0.001569 0.008587
849 PERIPHERAL NERVOUS SYSTEM NEURON DEVELOPMENT 6 13 0.001569 0.008587
850 REGULATION OF CELL FATE SPECIFICATION 6 13 0.001569 0.008587
851 REGULATION OF MEMBRANE LIPID DISTRIBUTION 11 37 0.001649 0.009004
852 IMPORT INTO CELL 11 37 0.001649 0.009004
853 BONE CELL DEVELOPMENT 8 22 0.001699 0.009258
854 CELLULAR RESPONSE TO INTERLEUKIN 6 8 22 0.001699 0.009258
855 MIDBRAIN DEVELOPMENT 20 90 0.001708 0.009295
856 SYNAPTIC SIGNALING 67 424 0.001711 0.009299
857 REGULATION OF LEUKOCYTE MIGRATION 29 149 0.001736 0.009427
858 POSITIVE REGULATION OF PROTEIN LOCALIZATION TO NUCLEUS 26 129 0.001753 0.009495
859 METANEPHRIC NEPHRON DEVELOPMENT 10 32 0.001753 0.009495
860 POSITIVE REGULATION OF HEART GROWTH 9 27 0.001786 0.009584
861 REGULATION OF ASTROCYTE DIFFERENTIATION 9 27 0.001786 0.009584
862 REGULATION OF PROTEIN LOCALIZATION TO CELL SURFACE 9 27 0.001786 0.009584
863 CARDIAC MUSCLE TISSUE MORPHOGENESIS 14 54 0.001778 0.009584
864 REGULATION OF RYANODINE SENSITIVE CALCIUM RELEASE CHANNEL ACTIVITY 9 27 0.001786 0.009584
865 PROTEIN LOCALIZATION TO NUCLEUS 30 156 0.001777 0.009584
866 CENTRAL NERVOUS SYSTEM NEURON AXONOGENESIS 9 27 0.001786 0.009584
867 FLUID TRANSPORT 9 27 0.001786 0.009584
868 REGULATION OF PHOSPHOPROTEIN PHOSPHATASE ACTIVITY 15 60 0.001839 0.009858
869 REGULATION OF HORMONE SECRETION 45 262 0.001845 0.009877
870 SMOOTHENED SIGNALING PATHWAY 17 72 0.001853 0.00991
NumGOOverlapSizeP ValueAdj. P Value
1 TRANSCRIPTION FACTOR ACTIVITY RNA POLYMERASE II CORE PROMOTER PROXIMAL REGION SEQUENCE SPECIFIC BINDING 90 328 1.185e-16 1.101e-13
2 ENZYME BINDING 296 1737 3.121e-15 1.45e-12
3 MOLECULAR FUNCTION REGULATOR 242 1353 6.589e-15 2.041e-12
4 RECEPTOR BINDING 256 1476 4.013e-14 9.319e-12
5 RNA POLYMERASE II TRANSCRIPTION FACTOR ACTIVITY SEQUENCE SPECIFIC DNA BINDING 132 629 1.78e-13 3.307e-11
6 CALCIUM ION BINDING 142 697 2.366e-13 3.664e-11
7 REGULATORY REGION NUCLEIC ACID BINDING 155 818 8.036e-12 1.066e-09
8 TRANSCRIPTIONAL ACTIVATOR ACTIVITY RNA POLYMERASE II TRANSCRIPTION REGULATORY REGION SEQUENCE SPECIFIC BINDING 75 315 8.255e-11 9.586e-09
9 RAS GUANYL NUCLEOTIDE EXCHANGE FACTOR ACTIVITY 60 228 9.39e-11 9.692e-09
10 CELL ADHESION MOLECULE BINDING 52 186 1.559e-10 1.448e-08
11 TRANSCRIPTIONAL ACTIVATOR ACTIVITY RNA POLYMERASE II CORE PROMOTER PROXIMAL REGION SEQUENCE SPECIFIC BINDING 59 226 1.894e-10 1.6e-08
12 TRANSMEMBRANE RECEPTOR PROTEIN KINASE ACTIVITY 30 81 8.329e-10 6.448e-08
13 GROWTH FACTOR BINDING 38 123 2.128e-09 1.521e-07
14 CYTOSKELETAL PROTEIN BINDING 146 819 2.733e-09 1.813e-07
15 PROTEIN DOMAIN SPECIFIC BINDING 118 624 3.065e-09 1.898e-07
16 MACROMOLECULAR COMPLEX BINDING 224 1399 3.856e-09 2.239e-07
17 ACTIN BINDING 83 393 4.266e-09 2.331e-07
18 NUCLEIC ACID BINDING TRANSCRIPTION FACTOR ACTIVITY 197 1199 4.742e-09 2.447e-07
19 GLYCOSAMINOGLYCAN BINDING 51 205 1.82e-08 8.897e-07
20 DOUBLE STRANDED DNA BINDING 135 764 1.924e-08 8.937e-07
21 GUANYL NUCLEOTIDE EXCHANGE FACTOR ACTIVITY 67 303 2.024e-08 8.952e-07
22 TRANSMEMBRANE RECEPTOR PROTEIN TYROSINE KINASE ACTIVITY 24 64 3.028e-08 1.247e-06
23 ENZYME REGULATOR ACTIVITY 161 959 3.088e-08 1.247e-06
24 TRANSCRIPTION FACTOR BINDING 99 524 6.025e-08 2.332e-06
25 PROTEIN DIMERIZATION ACTIVITY 185 1149 6.517e-08 2.422e-06
26 PROTEIN KINASE ACTIVITY 115 640 8.903e-08 3.181e-06
27 SMAD BINDING 25 72 9.258e-08 3.186e-06
28 KINASE BINDING 110 606 9.95e-08 3.301e-06
29 TRANSCRIPTION FACTOR ACTIVITY PROTEIN BINDING 107 588 1.306e-07 4.184e-06
30 INTEGRIN BINDING 31 105 1.982e-07 5.815e-06
31 TRANSCRIPTIONAL REPRESSOR ACTIVITY RNA POLYMERASE II CORE PROMOTER PROXIMAL REGION SEQUENCE SPECIFIC BINDING 31 105 1.982e-07 5.815e-06
32 RECEPTOR SIGNALING PROTEIN ACTIVITY 43 172 2.003e-07 5.815e-06
33 PROTEIN COMPLEX BINDING 154 935 2.132e-07 6.001e-06
34 TRANSCRIPTION FACTOR ACTIVITY RNA POLYMERASE II TRANSCRIPTION FACTOR BINDING 36 133 2.397e-07 6.549e-06
35 IDENTICAL PROTEIN BINDING 190 1209 2.506e-07 6.651e-06
36 KINASE ACTIVITY 141 842 2.657e-07 6.857e-06
37 TRANSCRIPTIONAL REPRESSOR ACTIVITY RNA POLYMERASE II TRANSCRIPTION REGULATORY REGION SEQUENCE SPECIFIC BINDING 42 168 2.763e-07 6.938e-06
38 ZINC ION BINDING 182 1155 3.793e-07 9.272e-06
39 CORE PROMOTER PROXIMAL REGION DNA BINDING 73 371 6.716e-07 1.6e-05
40 PDZ DOMAIN BINDING 27 90 8.401e-07 1.951e-05
41 PROTEIN HOMODIMERIZATION ACTIVITY 122 722 1.072e-06 2.43e-05
42 RHO GUANYL NUCLEOTIDE EXCHANGE FACTOR ACTIVITY 24 77 1.579e-06 3.48e-05
43 CHEMOREPELLENT ACTIVITY 13 27 1.611e-06 3.48e-05
44 TRANSITION METAL ION BINDING 210 1400 1.804e-06 3.794e-05
45 SEQUENCE SPECIFIC DNA BINDING 163 1037 1.838e-06 3.794e-05
46 HEPARIN BINDING 38 157 2.345e-06 4.735e-05
47 BETA CATENIN BINDING 25 84 2.49e-06 4.921e-05
48 COLLAGEN BINDING 21 65 3.687e-06 7.137e-05
49 CHANNEL REGULATOR ACTIVITY 33 131 4.219e-06 7.999e-05
50 EXTRACELLULAR MATRIX BINDING 18 51 4.4e-06 8.175e-05
51 GTPASE BINDING 59 295 4.509e-06 8.214e-05
52 LAMININ BINDING 13 30 6.981e-06 0.0001247
53 ION CHANNEL BINDING 29 111 7.359e-06 0.000129
54 NUCLEOSIDE TRIPHOSPHATASE REGULATOR ACTIVITY 63 329 9.493e-06 0.0001633
55 TRANSFERASE ACTIVITY TRANSFERRING PHOSPHORUS CONTAINING GROUPS 153 992 1.103e-05 0.0001863
56 TRANSFORMING GROWTH FACTOR BETA BINDING 9 16 1.352e-05 0.0002209
57 PHOSPHATIDYLINOSITOL 3 KINASE ACTIVITY 21 70 1.355e-05 0.0002209
58 EXTRACELLULAR MATRIX STRUCTURAL CONSTITUENT 22 76 1.602e-05 0.0002565
59 BHLH TRANSCRIPTION FACTOR BINDING 12 28 1.812e-05 0.0002853
60 CORE PROMOTER SEQUENCE SPECIFIC DNA BINDING 26 101 2.834e-05 0.0004388
61 TRANSCRIPTIONAL REPRESSOR ACTIVITY RNA POLYMERASE II ACTIVATING TRANSCRIPTION FACTOR BINDING 17 53 3.396e-05 0.0005172
62 SULFUR COMPOUND BINDING 47 234 3.615e-05 0.0005416
63 CYTOKINE BINDING 24 92 4.497e-05 0.0006631
64 GROWTH FACTOR RECEPTOR BINDING 30 129 5.833e-05 0.0008467
65 DIVALENT INORGANIC CATION TRANSMEMBRANE TRANSPORTER ACTIVITY 36 167 6.306e-05 0.0008876
66 ENZYME ACTIVATOR ACTIVITY 80 471 6.221e-05 0.0008876
67 LIPID BINDING 105 657 6.501e-05 0.0009014
68 NITRIC OXIDE SYNTHASE BINDING 9 19 8.006e-05 0.001078
69 TRANSCRIPTION COACTIVATOR ACTIVITY 55 296 7.962e-05 0.001078
70 ACTIVATING TRANSCRIPTION FACTOR BINDING 17 57 9.535e-05 0.001265
71 UDP GALACTOSYLTRANSFERASE ACTIVITY 11 28 0.000106 0.001386
72 PASSIVE TRANSMEMBRANE TRANSPORTER ACTIVITY 78 464 0.0001081 0.001395
73 TRANSPORTER ACTIVITY 183 1276 0.0001142 0.001454
74 GALACTOSYLTRANSFERASE ACTIVITY 12 33 0.0001246 0.001564
75 SH3 DOMAIN BINDING 27 116 0.0001317 0.001625
76 BINDING BRIDGING 36 173 0.0001347 0.001625
77 RNA POLYMERASE II TRANSCRIPTION FACTOR BINDING 25 104 0.0001335 0.001625
78 X1 PHOSPHATIDYLINOSITOL 3 KINASE ACTIVITY 14 43 0.0001379 0.001642
79 STEROID HORMONE RECEPTOR BINDING 21 81 0.0001447 0.001702
80 E BOX BINDING 12 34 0.0001733 0.002012
81 ORGANIC HYDROXY COMPOUND TRANSMEMBRANE TRANSPORTER ACTIVITY 17 60 0.0001914 0.002195
82 PROTEOGLYCAN BINDING 11 30 0.0002186 0.002414
83 TRANSMEMBRANE TRANSPORTER ACTIVITY 146 997 0.0002209 0.002414
84 GLYCOPROTEIN BINDING 24 101 0.0002177 0.002414
85 RAB GUANYL NUCLEOTIDE EXCHANGE FACTOR ACTIVITY 11 30 0.0002186 0.002414
86 PROTEIN SERINE THREONINE KINASE ACTIVITY 74 445 0.000225 0.002431
87 G PROTEIN COUPLED RECEPTOR BINDING 48 259 0.0002335 0.002494
88 RHO GTPASE BINDING 20 78 0.0002424 0.002559
89 CORE PROMOTER BINDING 32 152 0.0002477 0.002585
90 TRANSCRIPTION FACTOR ACTIVITY RNA POLYMERASE II DISTAL ENHANCER SEQUENCE SPECIFIC BINDING 22 90 0.0002553 0.002635
91 PHOSPHOLIPID BINDING 62 360 0.0002711 0.002767
92 PHOSPHATIDYLINOSITOL KINASE ACTIVITY 15 51 0.0002871 0.002899
93 STEROID BINDING 22 91 0.000302 0.003017
94 MAP KINASE KINASE KINASE ACTIVITY 9 22 0.0003164 0.0031
95 RNA POLYMERASE II ACTIVATING TRANSCRIPTION FACTOR BINDING 12 36 0.0003204 0.0031
96 RNA POLYMERASE II TRANSCRIPTION COACTIVATOR ACTIVITY 12 36 0.0003204 0.0031
97 GLUCOCORTICOID RECEPTOR BINDING 7 14 0.0003408 0.003264
98 TRANSCRIPTIONAL REPRESSOR ACTIVITY RNA POLYMERASE II TRANSCRIPTION FACTOR BINDING 21 86 0.0003546 0.003328
99 RIBONUCLEOTIDE BINDING 251 1860 0.0003542 0.003328
100 PROTEIN KINASE A BINDING 13 42 0.0004159 0.003864
101 ADENYL NUCLEOTIDE BINDING 208 1514 0.0004553 0.004188
102 GATED CHANNEL ACTIVITY 56 325 0.0005154 0.004393
103 STEROID HORMONE RECEPTOR ACTIVITY 16 59 0.0005036 0.004393
104 PHOSPHORIC ESTER HYDROLASE ACTIVITY 62 368 0.0004931 0.004393
105 ATPASE BINDING 19 76 0.000485 0.004393
106 TRANSCRIPTION COACTIVATOR BINDING 6 11 0.0005139 0.004393
107 PHOSPHOLIPID TRANSPORTER ACTIVITY 14 48 0.0004987 0.004393
108 PLATELET DERIVED GROWTH FACTOR BINDING 6 11 0.0005139 0.004393
109 CHROMATIN BINDING 71 435 0.0005151 0.004393
110 FIBRONECTIN BINDING 10 28 0.000539 0.004552
111 CALCIUM CHANNEL REGULATOR ACTIVITY 12 38 0.0005616 0.0047
112 X3 5 CYCLIC AMP PHOSPHODIESTERASE ACTIVITY 7 15 0.0005781 0.004753
113 RECEPTOR SERINE THREONINE KINASE BINDING 7 15 0.0005781 0.004753
114 ENZYME INHIBITOR ACTIVITY 63 378 0.0005968 0.004864
115 PHOSPHATIDYLINOSITOL BINDING 38 200 0.000607 0.004904
116 CALCIUM ION TRANSMEMBRANE TRANSPORTER ACTIVITY 27 128 0.0007043 0.00564
117 PROTEIN TYROSINE KINASE ACTIVITY 34 176 0.0008451 0.006711
118 PHOSPHATIDYLINOSITOL PHOSPHATE KINASE ACTIVITY 7 16 0.0009299 0.007273
119 ARYLSULFATASE ACTIVITY 6 12 0.0009317 0.007273
120 CYCLIC NUCLEOTIDE PHOSPHODIESTERASE ACTIVITY 9 25 0.0009551 0.007394
121 PROTEIN HETERODIMERIZATION ACTIVITY 74 468 0.0009987 0.007668
NumGOOverlapSizeP ValueAdj. P Value
1 MEMBRANE REGION 249 1134 9.986e-28 5.832e-25
2 PLASMA MEMBRANE REGION 202 929 5.331e-22 1.557e-19
3 EXTRACELLULAR MATRIX COMPONENT 51 125 9.337e-18 1.818e-15
4 PROTEINACEOUS EXTRACELLULAR MATRIX 96 356 3.941e-17 5.754e-15
5 EXTRACELLULAR MATRIX 108 426 5.268e-17 6.153e-15
6 CELL JUNCTION 219 1151 1.611e-16 1.568e-14
7 CELL SURFACE 160 757 2.148e-16 1.792e-14
8 MEMBRANE MICRODOMAIN 80 288 2.821e-15 2.059e-13
9 CELL PROJECTION 302 1786 4.423e-15 2.87e-13
10 CELL LEADING EDGE 90 350 8.813e-15 5.147e-13
11 NEURON PROJECTION 180 942 6.713e-14 3.564e-12
12 BASEMENT MEMBRANE 38 93 1.288e-13 6.268e-12
13 ANCHORING JUNCTION 109 489 4.454e-13 2.001e-11
14 NEURON PART 220 1265 2.346e-12 9.785e-11
15 POSTSYNAPSE 89 378 2.773e-12 1.08e-10
16 SYNAPSE 147 754 3.142e-12 1.147e-10
17 CELL CELL JUNCTION 89 383 5.979e-12 2.054e-10
18 INTRINSIC COMPONENT OF PLASMA MEMBRANE 266 1649 4.928e-11 1.599e-09
19 CELL SUBSTRATE JUNCTION 88 398 1.273e-10 3.914e-09
20 SYNAPSE PART 118 610 7.584e-10 2.214e-08
21 LAMELLIPODIUM 48 172 8.351e-10 2.322e-08
22 APICAL PART OF CELL 79 361 1.855e-09 4.925e-08
23 GOLGI APPARATUS 229 1445 6.318e-09 1.604e-07
24 DENDRITE 91 451 8.334e-09 2.028e-07
25 SARCOLEMMA 37 125 1.256e-08 2.934e-07
26 SOMATODENDRITIC COMPARTMENT 119 650 1.814e-08 4.074e-07
27 PLASMA MEMBRANE RAFT 29 86 1.888e-08 4.084e-07
28 CELL CELL CONTACT ZONE 24 64 3.028e-08 6.315e-07
29 CELL PROJECTION PART 159 946 3.493e-08 7.033e-07
30 RECEPTOR COMPLEX 70 327 3.914e-08 7.62e-07
31 I BAND 35 121 5.859e-08 1.046e-06
32 APICAL PLASMA MEMBRANE 64 292 5.91e-08 1.046e-06
33 PLASMA MEMBRANE PROTEIN COMPLEX 97 510 5.869e-08 1.046e-06
34 CONTRACTILE FIBER 50 211 1.311e-07 2.252e-06
35 INTERCALATED DISC 20 51 1.797e-07 2.915e-06
36 BASAL PART OF CELL 20 51 1.797e-07 2.915e-06
37 INTRACELLULAR VESICLE 197 1259 2.04e-07 3.22e-06
38 AXON 80 418 6.458e-07 9.926e-06
39 LEADING EDGE MEMBRANE 35 134 8.816e-07 1.32e-05
40 EXTRACELLULAR SPACE 208 1376 1.177e-06 1.719e-05
41 COMPLEX OF COLLAGEN TRIMERS 12 23 1.37e-06 1.951e-05
42 EXCITATORY SYNAPSE 45 197 1.61e-06 2.239e-05
43 CYTOPLASMIC REGION 59 287 1.809e-06 2.402e-05
44 SYNAPTIC MEMBRANE 55 261 1.81e-06 2.402e-05
45 PERINUCLEAR REGION OF CYTOPLASM 110 642 1.863e-06 2.417e-05
46 RUFFLE 38 156 1.986e-06 2.522e-05
47 FILOPODIUM 27 94 2.149e-06 2.671e-05
48 TRANSCRIPTION FACTOR COMPLEX 60 298 3.006e-06 3.657e-05
49 ENDOPLASMIC RETICULUM 236 1631 5.975e-06 7.121e-05
50 CELL PROJECTION MEMBRANE 59 298 6.262e-06 7.314e-05
51 ENDOPLASMIC RETICULUM LUMEN 44 201 6.805e-06 7.793e-05
52 APICAL JUNCTION COMPLEX 32 128 6.959e-06 7.815e-05
53 ACTIN CYTOSKELETON 80 444 7.213e-06 7.947e-05
54 SITE OF POLARIZED GROWTH 35 149 1.169e-05 0.0001241
55 POSTSYNAPTIC MEMBRANE 44 205 1.155e-05 0.0001241
56 CELL CORTEX 49 238 1.256e-05 0.000131
57 T TUBULE 16 45 1.335e-05 0.0001367
58 CYTOSKELETON 275 1967 1.459e-05 0.0001469
59 SIDE OF MEMBRANE 76 428 2.044e-05 0.0002024
60 BASOLATERAL PLASMA MEMBRANE 44 211 2.454e-05 0.0002349
61 BASAL PLASMA MEMBRANE 13 33 2.427e-05 0.0002349
62 ACTIN BASED CELL PROJECTION 39 181 3.226e-05 0.0003039
63 FIBRIL 8 14 3.6e-05 0.0003338
64 RUFFLE MEMBRANE 22 80 3.857e-05 0.0003519
65 NUCLEAR ENVELOPE 73 416 4.407e-05 0.0003959
66 GOLGI APPARATUS PART 136 893 6.213e-05 0.0005431
67 ENDOSOME 123 793 6.231e-05 0.0005431
68 NEURON SPINE 28 121 0.0001111 0.0009541
69 EXTRINSIC COMPONENT OF MEMBRANE 48 252 0.000119 0.001007
70 BASAL LAMINA 9 21 0.0002072 0.001729
71 LATERAL PLASMA MEMBRANE 15 50 0.0002255 0.001855
72 COATED PIT 18 67 0.0002615 0.002121
73 SARCOPLASM 18 68 0.0003193 0.002554
74 PLASMA MEMBRANE RECEPTOR COMPLEX 35 175 0.0003673 0.002899
75 EXTERNAL SIDE OF PLASMA MEMBRANE 44 238 0.0004386 0.003415
76 COLLAGEN TRIMER 21 88 0.0004943 0.003799
77 AXON PART 41 219 0.0005184 0.003931
78 CELL CELL ADHERENS JUNCTION 15 54 0.000566 0.004238
79 MEMBRANE PROTEIN COMPLEX 146 1020 0.0006052 0.004474
80 NUCLEAR MEMBRANE 49 280 0.0007856 0.005735
81 ACTOMYOSIN 16 62 0.0009108 0.006567
82 PROTEIN COMPLEX INVOLVED IN CELL ADHESION 10 30 0.001003 0.007145
83 ACTIN FILAMENT BUNDLE 15 57 0.001048 0.007377
84 CELL CORTEX PART 25 119 0.001157 0.008046
85 GLYCOPROTEIN COMPLEX 8 21 0.001196 0.00822
86 CORTICAL ACTIN CYTOSKELETON 15 58 0.001272 0.008636
87 DESMOSOME 9 26 0.001319 0.008851
88 VACUOLE 163 1180 0.001475 0.009681
89 NEURONAL POSTSYNAPTIC DENSITY 14 53 0.001464 0.009681

Over-represented Pathway

NumPathwayPathviewOverlapSizeP ValueAdj. P Value
1 hsa04510_Focal_adhesion 60 200 2.192e-13 3.946e-11
2 hsa04512_ECM.receptor_interaction 31 85 6.832e-10 6.149e-08
3 hsa04151_PI3K_AKT_signaling_pathway 77 351 2.645e-09 1.587e-07
4 hsa04360_Axon_guidance 37 130 3.961e-08 1.783e-06
5 hsa04350_TGF.beta_signaling_pathway 28 85 5.864e-08 2.111e-06
6 hsa04014_Ras_signaling_pathway 54 236 1.444e-07 4.331e-06
7 hsa04810_Regulation_of_actin_cytoskeleton 50 214 2.091e-07 5.376e-06
8 hsa04010_MAPK_signaling_pathway 57 268 8.666e-07 1.95e-05
9 hsa04540_Gap_junction 26 90 2.93e-06 5.86e-05
10 hsa04270_Vascular_smooth_muscle_contraction 30 116 6.437e-06 0.0001159
11 hsa04020_Calcium_signaling_pathway 40 177 7.853e-06 0.0001285
12 hsa04390_Hippo_signaling_pathway 35 154 2.486e-05 0.0003728
13 hsa04971_Gastric_acid_secretion 21 74 3.443e-05 0.0004767
14 hsa04310_Wnt_signaling_pathway 33 151 9.456e-05 0.001216
15 hsa04320_Dorso.ventral_axis_formation 10 25 0.0001833 0.002199
16 hsa04970_Salivary_secretion 22 89 0.000215 0.002305
17 hsa04916_Melanogenesis 24 101 0.0002177 0.002305
18 hsa04722_Neurotrophin_signaling_pathway 28 127 0.0002653 0.002643
19 hsa04520_Adherens_junction 19 73 0.000279 0.002643
20 hsa04730_Long.term_depression 18 70 0.0004689 0.00422
21 hsa04972_Pancreatic_secretion 23 101 0.0005588 0.00479
22 hsa04070_Phosphatidylinositol_signaling_system 19 78 0.0006861 0.005614
23 hsa04012_ErbB_signaling_pathway 20 87 0.001099 0.008405
24 hsa04974_Protein_digestion_and_absorption 19 81 0.001121 0.008405
25 hsa04630_Jak.STAT_signaling_pathway 30 155 0.001601 0.01153
26 hsa04710_Circadian_rhythm_._mammal 8 23 0.002355 0.01631
27 hsa04912_GnRH_signaling_pathway 21 101 0.003145 0.02097
28 hsa04720_Long.term_potentiation 16 70 0.003528 0.02268
29 hsa00565_Ether_lipid_metabolism 10 36 0.004577 0.02841
30 hsa04960_Aldosterone.regulated_sodium_reabsorption 11 42 0.004918 0.02951
31 hsa00601_Glycosphingolipid_biosynthesis_._lacto_and_neolacto_series 8 26 0.00555 0.03223
32 hsa02010_ABC_transporters 11 44 0.00717 0.04033
33 hsa04514_Cell_adhesion_molecules_.CAMs. 25 136 0.007419 0.04047
34 hsa00760_Nicotinate_and_nicotinamide_metabolism 7 24 0.01274 0.06743
35 hsa00512_Mucin_type_O.Glycan_biosynthesis 8 30 0.01394 0.07012
36 hsa00603_Glycosphingolipid_biosynthesis_._globo_series 5 14 0.01402 0.07012
37 hsa04670_Leukocyte_transendothelial_migration 21 117 0.01723 0.08382
38 hsa04380_Osteoclast_differentiation 22 128 0.02393 0.1133
39 hsa04144_Endocytosis 32 203 0.02512 0.1139
40 hsa04664_Fc_epsilon_RI_signaling_pathway 15 79 0.0253 0.1139
41 hsa00600_Sphingolipid_metabolism 9 40 0.02802 0.123
42 hsa04530_Tight_junction 22 133 0.03526 0.1511
43 hsa04610_Complement_and_coagulation_cascades 13 69 0.03775 0.158
44 hsa00562_Inositol_phosphate_metabolism 11 57 0.0458 0.1849
45 hsa04976_Bile_secretion 13 71 0.04624 0.1849
46 hsa04666_Fc_gamma_R.mediated_phagocytosis 16 95 0.05705 0.2233
47 hsa04640_Hematopoietic_cell_lineage 15 88 0.05862 0.2245
48 hsa04062_Chemokine_signaling_pathway 28 189 0.06668 0.246
49 hsa04662_B_cell_receptor_signaling_pathway 13 75 0.06698 0.246
50 hsa04920_Adipocytokine_signaling_pathway 12 68 0.06836 0.2461
51 hsa00604_Glycosphingolipid_biosynthesis_._ganglio_series 4 15 0.07545 0.2663
52 hsa04340_Hedgehog_signaling_pathway 10 56 0.08533 0.2954
53 hsa04914_Progesterone.mediated_oocyte_maturation 14 87 0.09656 0.3279
54 hsa04962_Vasopressin.regulated_water_reabsorption 8 44 0.1072 0.3573
55 hsa04114_Oocyte_meiosis 17 114 0.1243 0.4006
56 hsa03015_mRNA_surveillance_pathway 13 83 0.1246 0.4006
57 hsa04370_VEGF_signaling_pathway 12 76 0.1305 0.412
58 hsa04146_Peroxisome 12 79 0.1598 0.496
59 hsa00564_Glycerophospholipid_metabolism 12 80 0.1703 0.5196
60 hsa00380_Tryptophan_metabolism 7 42 0.177 0.531
61 hsa04210_Apoptosis 13 89 0.1819 0.5366
62 hsa04910_Insulin_signaling_pathway 19 138 0.1871 0.5433
63 hsa04973_Carbohydrate_digestion_and_absorption 7 44 0.2088 0.5958
64 hsa04660_T_cell_receptor_signaling_pathway 15 108 0.2118 0.5958
65 hsa03022_Basal_transcription_factors 6 37 0.2206 0.611
66 hsa00533_Glycosaminoglycan_biosynthesis_._keratan_sulfate 3 15 0.2264 0.6139
67 hsa04260_Cardiac_muscle_contraction 11 77 0.2285 0.6139
68 hsa00230_Purine_metabolism 21 162 0.2527 0.6618
69 hsa00120_Primary_bile_acid_biosynthesis 3 16 0.2574 0.6618
70 hsa00770_Pantothenate_and_CoA_biosynthesis 3 16 0.2574 0.6618
71 hsa04142_Lysosome 16 121 0.2621 0.6644
72 hsa00982_Drug_metabolism_._cytochrome_P450 10 73 0.2857 0.7123
73 hsa00450_Selenocompound_metabolism 3 17 0.2889 0.7123
74 hsa00430_Taurine_and_hypotaurine_metabolism 2 10 0.3053 0.7427
75 hsa00670_One_carbon_pool_by_folate 3 18 0.3206 0.7642
76 hsa00590_Arachidonic_acid_metabolism 8 59 0.3269 0.7642
77 hsa04621_NOD.like_receptor_signaling_pathway 8 59 0.3269 0.7642
78 hsa04620_Toll.like_receptor_signaling_pathway 13 102 0.3378 0.7795
79 hsa00740_Riboflavin_metabolism 2 11 0.3479 0.7928
80 hsa00531_Glycosaminoglycan_degradation 3 19 0.3524 0.7928
81 hsa00270_Cysteine_and_methionine_metabolism 5 36 0.3675 0.8113
82 hsa03320_PPAR_signaling_pathway 9 70 0.3696 0.8113
83 hsa00592_alpha.Linolenic_acid_metabolism 3 20 0.3839 0.8147
84 hsa00980_Metabolism_of_xenobiotics_by_cytochrome_P450 9 71 0.3859 0.8147
85 hsa00330_Arginine_and_proline_metabolism 7 54 0.3892 0.8147
86 hsa00340_Histidine_metabolism 4 29 0.402 0.8318
87 hsa00591_Linoleic_acid_metabolism 4 30 0.428 0.8575
88 hsa00920_Sulfur_metabolism 2 13 0.4301 0.8575
89 hsa04650_Natural_killer_cell_mediated_cytotoxicity 16 136 0.437 0.8575
90 hsa00410_beta.Alanine_metabolism 3 22 0.4458 0.8575
91 hsa00532_Glycosaminoglycan_biosynthesis_._chondroitin_sulfate 3 22 0.4458 0.8575
92 hsa04110_Cell_cycle 15 128 0.4478 0.8575
93 hsa04145_Phagosome 18 156 0.4626 0.8764
94 hsa00910_Nitrogen_metabolism 3 23 0.4758 0.8764
95 hsa04964_Proximal_tubule_bicarbonate_reclamation 3 23 0.4758 0.8764
96 hsa00640_Propanoate_metabolism 4 32 0.479 0.8764
97 hsa00480_Glutathione_metabolism 6 50 0.482 0.8764
98 hsa04115_p53_signaling_pathway 8 69 0.5006 0.9004
99 hsa04150_mTOR_signaling_pathway 6 52 0.5215 0.9204
100 hsa00563_Glycosylphosphatidylinositol.GPI..anchor_biosynthesis 3 25 0.5334 0.9322
101 hsa00534_Glycosaminoglycan_biosynthesis_._heparan_sulfate 3 26 0.5608 0.9614
102 hsa00360_Phenylalanine_metabolism 2 17 0.5758 0.9686
103 hsa00511_Other_glycan_degradation 2 17 0.5758 0.9686
104 hsa04120_Ubiquitin_mediated_proteolysis 15 139 0.5814 0.969
105 hsa04330_Notch_signaling_pathway 5 47 0.6061 1
106 hsa00140_Steroid_hormone_biosynthesis 6 57 0.6143 1
107 hsa00350_Tyrosine_metabolism 4 41 0.6792 1
108 hsa04622_RIG.I.like_receptor_signaling_pathway 7 71 0.683 1
109 hsa04141_Protein_processing_in_endoplasmic_reticulum 17 168 0.6887 1
110 hsa01040_Biosynthesis_of_unsaturated_fatty_acids 2 21 0.6923 1
111 hsa00250_Alanine._aspartate_and_glutamate_metabolism 3 32 0.7032 1
112 hsa00071_Fatty_acid_metabolism 4 43 0.7155 1
113 hsa04977_Vitamin_digestion_and_absorption 2 24 0.7612 1
114 hsa00053_Ascorbate_and_aldarate_metabolism 2 26 0.7994 1
115 hsa00510_N.Glycan_biosynthesis 4 49 0.8061 1
116 hsa00561_Glycerolipid_metabolism 4 50 0.8186 1
117 hsa00620_Pyruvate_metabolism 3 40 0.8345 1
118 hsa03020_RNA_polymerase 2 29 0.8465 1
119 hsa04744_Phototransduction 2 29 0.8465 1
120 hsa00500_Starch_and_sucrose_metabolism 4 54 0.8623 1
121 hsa00310_Lysine_degradation 3 44 0.879 1
122 hsa00260_Glycine._serine_and_threonine_metabolism 2 32 0.8833 1
123 hsa04975_Fat_digestion_and_absorption 3 46 0.8969 1
124 hsa04672_Intestinal_immune_network_for_IgA_production 3 49 0.9194 1
125 hsa00830_Retinol_metabolism 4 64 0.934 1
126 hsa00983_Drug_metabolism_._other_enzymes 3 52 0.9373 1
127 hsa04742_Taste_transduction 3 52 0.9373 1
128 hsa00010_Glycolysis_._Gluconeogenesis 4 65 0.9389 1
129 hsa04623_Cytosolic_DNA.sensing_pathway 3 56 0.9555 1
130 hsa03018_RNA_degradation 4 71 0.9619 1
131 hsa00280_Valine._leucine_and_isoleucine_degradation 2 44 0.963 1
132 hsa03420_Nucleotide_excision_repair 2 45 0.9664 1
133 hsa00240_Pyrimidine_metabolism 6 99 0.9692 1
134 hsa00520_Amino_sugar_and_nucleotide_sugar_metabolism 2 48 0.9751 1
135 hsa03013_RNA_transport 8 152 0.9959 1
136 hsa04612_Antigen_processing_and_presentation 2 78 0.9989 1
137 hsa00190_Oxidative_phosphorylation 2 132 1 1
138 hsa03040_Spliceosome 3 128 1 1
139 hsa04740_Olfactory_transduction 9 388 1 1

Quest ID: fa6cf0651ea6a25380572bd86d5760e1